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ABSTRACT 
Certain pitfalls associated with propensity score matching have come to light, recently. 
The extent to which these pitfalls might threaten validity and precision in 
pharmacoepidemiologic research, for which propensity score matching often is used, is 
uncertain. We evaluated the “propensity score matching paradox” – the tendency for 
covariate imbalance to increase in a propensity score-matched dataset upon continuous 
pruning of matched sets – as well as the utility of coarsened exact matching, a technique 
that has been posed as a preferable alternative to propensity score matching, especially in 
light of the “propensity score matching paradox”. We show that the “propensity score 
matching paradox” may not threaten causal inference that is based on propensity score 
matching in typical pharmacoepidemiologic settings to the extent predicted by previous 
research. Moreover, even though coarsened exact matching substantially improves 
covariate balance, it may not be optimal in typical pharmacoepidemiologic settings due to 
the extreme loss of study size (and resulting increase in bias and variance) that may be 
required to build the matched dataset. Finally, we explain variability in 1:1 propensity 
score matching without replacement as well as methods that were developed to account 
for this variability, with application of these methods to an example claims-based study.  
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CHAPTER ONE: IMPLICATIONS OF THE PROPENSITY SCORE MATCHING 
PARADOX IN PHARMACOEPIDEMIOLOGY1  
 
INTRODUCTION 
Propensity score matching (PSM) is a popular method to control for differences in 
propensity score distributions in observational research [Pearl, 2010; Hade and Lu, 2014; 
Wu et al., 2015]. Other methods, notably stratification by propensity score, may be 
preferable with respect to overall efficiency, but PSM remains popular, perhaps owing to 
its reduction of the matching process to one dimension [Rosenbaum and Rubin, 1983; 
D'Agostino, 1998; Pearl, 2010; Desai et al., 2017]. With PSM, index units are matched to 
reference units with similar propensity score values, even though their underlying 
covariate profiles might be dissimilar. Even with this underlying dissimilarity, the 
distributions of observed covariates should be similar, on average, between index and 
reference units, conditional on the propensity score [Rosenbaum and Rubin, 1983; 
Austin, 2011]. From a practical perspective, PSM is easily understood among researchers 
and is easily implemented with available algorithms [Rassen et al., 2012].  
 
King and Nielsen recently argued that PSM should be avoided because of the potential 
for the “PSM paradox” to degrade causal inference [King and Nielsen, 2016]. The 
paradox, in brief, is: for datasets that already are well-balanced on measured covariates, 
pruning of matched sets with the largest propensity score distances between the index and 
                                                          





reference units may lead to increased imbalance in the underlying covariate distributions 
between exposure groups and, thus, to increased bias in the effect estimate. 
 
Because King and Nielsen demonstrated the paradox in datasets with fewer covariates 
and with better initial covariate balance than what typically is encountered in 
pharmacoepidemiology, the practical effect of the paradox in pharmacoepidemiologic 
analyses is not clear.  
  
Here, we present a description of the paradox and the results of an analysis of the impact 
of the paradox in pharmacoepidemiologic applications using insurance claims data. We 
used methods similar to those used by King and Nielsen in order to track levels of 
imbalance produced by progressive pruning of matched pairs from datasets in which, 
initially, all index units are matched. We varied a number of key parameters in the 
matching process, generating multiple matched datasets. Our intent was to evaluate the 
practical implications of the theoretical findings of King and Nielsen.   
 
THE PSM PARADOX 
The standard approach to 1:1 PSM for a dichotomous exposure is: (1) generate 
propensity scores corresponding to the estimated probability of receiving the index 
exposure, conditional on observed covariates, for every unit in a dataset (commonly via 
logistic regression); (2) match a reference unit to each index unit via some algorithm 





with the largest propensity score distances in order to eliminate poorly-matched units and 
to ensure balanced propensity score distributions (usually via application of a caliper as 
part of step 2); (4) compare (usually at the univariate level) pre- and post-matched 
covariate distributions to assess the improvement in covariate balance due to PSM; (5) 
estimate the effect parameter of interest in the matched dataset [Pan and Bai, 2015]. The 
key benefit of matching on the propensity score is the dimension reduction that allows for 
efficient matching on a scalar summary of a potentially large vector of covariates.  
 
Let X be the vector of observed covariates that inform the propensity score model. PSM 
guarantees balance among the matched sets on the conditional probability of exposure, 
Pr(Exposure|X), but it guarantees balance on X only asymptotically [Mielke and Berry, 
2007; Iacus et al., 2011]. With asymptotic balance, any pruning of matched sets from the 
resulting dataset is expected to be random with respect to underlying covariate balance. 
The reduction in study size resulting from random pruning could, by chance, increase the 
underlying X distance between matched units. Thus, although the intent of pruning 
propensity score-matched sets is to increase covariate balance, this process could have 
the opposite effect. By extension, with better covariate balance prior to any matching or 
pruning, it becomes more likely that balance will begin to deteriorate after only a few 
prunings. If the same procedure of pruning the worst-matched units is applied in the 
context of matching on the actual components of X, rather than on the scalar propensity 
score, an increase in imbalance is not expected because distances between the original 





and L., 2007; Hill, 2008; Imai et al., 2008; Imai et al., 2009].   
 
We present a simple example of this phenomenon using only two covariates in Table 1. 
In this population of 12, 4 are exposed to the index exposure and 8 are exposed to the 
reference exposure. The distributions of sex and race in this population are perfectly 
balanced between the two exposure groups. The propensity score for every unit is 
Pr(Index Exposure|Sex, Race) = 1/3. If 1:1 PSM without replacement is performed, there 
should be no algorithmic preference to match any reference unit to any index unit, since 
all 12 units have the same propensity score value. There are 70 possible selections of 4 
reference units from the pool of 8 reference units to build the matched cohort consisting 
of 8 total units. Only 16 of those selections will retain perfect covariate balance in the 
sex-race distribution. Thus, we expect that 77% of the time, covariate balance will be 
worse after the initial pruning of units via PSM, compared with the balance in the pre-
matched dataset. This phenomenon occurs even though the distribution of propensity 
scores will be perfectly balanced in any matched dataset. If either of these two covariates 
is related to outcome, we expect the covariate imbalance to correspond to bias in the 
treatment effect estimate.  
 
Unlike our example dataset, the typical pharmacoepidemiologic claims dataset, which 
comprises a large number of patients and a large number of potential confounders of an 
association between a drug and health outcome (e.g., corresponding to concomitant 





Urquhart, 1991; Patorno et al., 2013; Patorno et al., 2014]. Thus, we expected to observe 
a notable improvement in balance after PSM long before pruning could worsen balance. 
 
METHODS 
Description of Datasets  
Two retrospective cohorts were used in these analyses. The first was a cohort of 49,919 
low-income Medicare beneficiaries, at least 65 years of age, who were enrolled in the 
Pharmaceutical Assistance Contract for the Elderly (PACE) database in New Jersey over 
the years 1999-2002 and who initiated non-selective NSAIDs or selective COX-2 
inhibitors [Brookhart et al., 2006; Schneeweiss et al., 2006]. The PACE cohort was 
generated to perform an analysis of the effect of selective COX-2 inhibitors, compared 
with non-selective NSAIDs, on the risk of gastrointestinal complications. Approximately 
60% of patients represented in this cohort were selective COX-2 inhibitor initiators. 
Approximately 2,000 cases of gastrointestinal complication were observed in this cohort.  
 
The second cohort comprised information on 886,996 completed pregnancies and was 
generated from the Medicaid Analytic eXtract (MAX) over the years 2000-2007 
[Huybrechts et al., 2014; Bateman et al., 2015; Desai et al., 2017]. The MAX cohort was 
used to perform an analysis of the effect of statin use during the first trimester of 
pregnancy, compared with no use during the first trimester of pregnancy, on the risk of 
congenital malformation in the infant. Statin use was defined as the existence of at least 





women represented in this cohort filled a statin prescription during the first trimester. 
Approximately 30,000 congenital malformations were observed in this cohort.  
 
Creation of Matched Datasets  
We created multiple 1:1-matched datasets using propensity scores generated via logistic 
regression. In order to relax distributional assumptions for the propensity score models, 
all continuous variables were categorized. The propensity score models based on PACE 
predicted the probability of exposure to non-selective NSAIDs (since there were fewer 
non-selective NSAID initiators than selective COX-2 inhibitor initiators), while the 
propensity score models based on MAX predicted the probability of exposure to statins. 
Each matched dataset represented a different manipulation of (1) the richness of the 
covariate set informing the propensity score model, (2) the prevalence of index exposure 
in the pre-matched dataset and (3) the matching algorithm.  
 
Covariate Set Richness  
To assess whether increasing the number of covariates in the propensity score model 
decreases the number of prunings required for covariate imbalance to increase, we used 
three PACE-based covariate sets. The first covariate set, “Small”, comprised 19 
covariates that were selected based on clinical importance. The second and third 
covariate sets (“Standard” and “Large”, respectively) comprised additional covariates 
(representing concomitant medications, comorbidities and other medical encounters) 





2009], in addition to the 19 pre-determined covariates. The 50 covariates with the highest 
bias-based HDPS ranks were included in the “Standard” covariate set, and the 100 
covariates with the highest bias-based HDPS ranks were included in the “Large” 
covariate set. All models generated from MAX were based on one covariate set 
comprising 20 categorical covariates, which were selected based on clinical importance.  
 
Prevalence of Index Exposure in the Pre-matched Dataset 
To determine how the size of the fully-matched dataset affects covariate balance during 
matched set pruning, the index exposure prevalence values of PACE and MAX were 
varied, via simple random sampling with replacement, but the original dataset sizes were 
retained. Matched datasets were generated from PACE, separately for each of the three 
covariate set scenarios, using the original index exposure prevalence, 50% of the original 
index exposure prevalence and 20% of the original index exposure prevalence. Matched 
datasets were generated from MAX using the original index exposure prevalence, 400% 




Since the matching quality may depend on the matching algorithm, we used two 1:1 PSM 
algorithms that have been used in previous pharmacoepidemiologic analyses: a variation 
of nearest neighbor matching (NNM) and a variation of Parson’s digit-based greedy 





the overall propensity score distance among matched sets, the latter algorithm matches 
units on decreasing levels of precision, up to the fifth digit of the propensity score, 
without consideration of overall distance. 
 
Because King and Nielsen referred to Mahalanobis distance matching (MDM) as a 
potentially better option than PSM for maintaining covariate balance after matching, we 
also implemented MDM [King et al., 2011; King and Nielsen, 2016]. Like the propensity 
score, the Mahalanobis distance is a scalar summary of the original covariate space. 
However, unlike the propensity score, it is a direct representation of distance between 
units in the actual covariate space, and has the following form: 
√[(Xi-Xj)’Σ
-1(Xi-Xj)], 
where i indexes the exposed unit, j indexes the unexposed unit, X is the vector of 
covariates for a given unit and Σ is the sample covariance matrix of the original data 
[Iacus et al., 2011]. We selected a nearest neighbor matching algorithm to implement 
MDM given the popularity of this algorithm for MDM [Ho et al., 2007; Ho et al., 2011].   
 
We constructed 12 unique datasets (9 PACE datasets, 3 MAX datasets) and 36 unique 
matching scenarios for our analysis. Our manipulation strategy is summarized in Figure 
1.   
 
Pruning and Assessment of Imbalance 





absolute propensity score distance or Mahalanobis distance and the matched pair with the 
largest distance was pruned from the dataset. Covariate balance was assessed for the 
remaining dataset, then the matched pair with the largest distance in the remaining dataset 
was pruned and covariate balance was assessed again. This process was repeated until 
only a single matched pair was left in the dataset.  
 
We used two metrics to summarize covariate imbalance: the Mahalanobis balance and the 
c-statistic. The Mahalanobis balance is a type of Mahalanobis distance that represents the 
extent of covariate balance in the actual covariate space, and has the following form:  
√[(?̅?T1-?̅?T0)’Σ -1(?̅?T1-?̅?T0)],  
where ?̅?Tk is the vector of covariate means in exposure group k, and Σ is the sample 
covariance matrix of the original data [Gu and Rosenbaum, 1993; Franklin et al., 2014]. 
Higher Mahalanobis balance values indicate worse covariate balance. We used the c-
statistic to determine changes in the discriminatory power of the logistic model predicting 
index exposure in the matched dataset [Harrell et al., 1982; Harrell et al., 1984]. Balance 
on the covariates in the matched dataset should lead to poor ability of the corresponding 
logistic model to determine which units are exposed (i.e., c-statistics near 0.5) [Franklin 
et al., 2014]. Thus, higher c-statistic values (greater than 0.5) indicate worse covariate 
balance. 
 
The points in the pruning process at which three absolute propensity score distance 





our calipers from the common range, [0.01, 0.05] [Oakes and Kaufman, 2017]. We 
focused on a 0.05 caliper and then applied the more conservative calipers of 0.025 and 
0.01 in order to determine whether the further loss of matched sets would correspond to 
increased covariate imbalance. Each caliper criterion was satisfied when the maximum 
propensity score distance between two units of a matched pair in a pruned dataset was 
less than the caliper value.  
 
Tracking Changes in the Effect Estimate 
We calculated and plotted a point estimate of effect after each pruning. For PACE, we 
calculated the RR estimate corresponding to the effect of non-selective NSAIDs, 
compared with COX-2 inhibitors, on the risk of gastrointestinal complications. For MAX, 
we calculated the RR estimate corresponding to the effect of statin use during the first 
trimester of pregnancy, compared with no use during the first trimester of pregnancy, on 
the risk of congenital malformation. Our goal in generating these graphs was to depict the 
pattern describing how the paradox might lead to bias in the effect estimate.  
 
RESULTS 
We display example covariate distributions for the pre-matched dataset and for the fully-
matched datasets for PACE and MAX in Tables 2 and 3, respectively. These tables 
indicate that covariate balance in the pre-matched dataset was far worse for MAX than 
for PACE. In both datasets, covariate balance improved after the creation of the fully-





MDM (Table 2). For MAX, the opposite was true (Table 3). We also analyzed 
standardized differences and drew the same conclusions (Figures 2 and 3) [Austin, 2009]. 
 
We display all Mahalanobis balance metric trend graphs for PACE and MAX in Figures 
4 and 5, respectively. The c-statistic metric trend graphs were similar and are displayed in 
Figures 6 and 7 for PACE and MAX, respectively. We also present zoomed-in versions 
of Figures 4 and 5 in Figures 8 and 9, respectively. 
 
In each panel of Figures 4 and 5, the fully-matched datasets produced by NNM and by 
DGM had much better covariate balance than the corresponding pre-matched dataset, 
although this was not always the case for MDM – in one case, balance actually was 
worse for MDM in the fully-matched dataset (Figure 4, panel G). Moreover, the points at 
which the caliper criteria were met always were near the lowest regions of the NNM and 
DGM trend lines. These results indicate that if a typical caliper on the absolute propensity 
score scale in the range, [0.01, 0.05] had been required after NNM or DGM, before 
performing inference on these data, the covariate balance in the corresponding pruned 
dataset always would have been near optimal (at least, measured by the Mahalanobis 
balance). However, even though NNM and DGM always greatly improved covariate 
balance with respect to the pre-matched datasets after only a few prunings, covariate 





Covariate Set Richness 
For the PACE NNM- and DGM-matched datasets, for a given index exposure prevalence, 
fewer prunings were required for covariate imbalance to increase as the number of 
covariates used to construct the corresponding propensity score model increased (Figure 
4). This result is demonstrated by the fact that the imbalance trends increased more 
quickly during the pruning process as the number of covariates increased, or by the fact 
that the Mahalanobis balance value of the fully-matched dataset increased as the number 
of covariates increased, or both. A similar trend occurred for the PACE MDM-matched 
datasets. As the number of covariates used to perform MDM increased, the Mahalanobis 
balance value of the fully-matched dataset increased. Finally, increasing the number of 
covariates used to construct the propensity score model generally increased the number of 
prunings required to achieve the caliper criteria (Figure 8).  
 
Prevalence of Index Exposure in the Pre-matched Dataset 
No consistently strong trends in imbalance across index exposure prevalence levels were 
noted, although the largest index exposure prevalence scenarios for PACE and MAX 
always required more prunings to minimize imbalance. This relation was especially clear 
for PACE (Figure 4, panels A, D and G). Also, for a given covariate set size, lower index 
exposure prevalence values always corresponded to fewer prunings required to achieve 







The differences between the performances of NNM and DGM in reducing imbalance 
were not substantial in any scenario. For MAX, MDM performed better overall than 
NNM and DGM with respect to maintaining low covariate imbalance (Figure 5). 
However, for PACE, as the number of covariates used to build the propensity score 
model increased, MDM performance became increasingly worse, as evidenced by the 
elevated MDM trend lines (Figure 4). Finally, all MDM imbalance trends were 
effectively monotonic decreasing, whereas the paradox was visible in some cases for the 
NNM and DGM trends.  
 
Tracking Changes in the Effect Estimate 
The RR estimate trends for PACE and MAX are displayed in Figures 10 and 11, 
respectively. We found that, in general, the NNM and DGM trends were similar, 
especially at the left-most portion of each panel (i.e., in the caliper regions). For PACE, 
in the larger covariate set scenarios, the MDM trends indicated RR estimates further from 
the null than did the NNM and DGM trends, whereas in the Small PACE scenarios and in 
all MAX scenarios, all three algorithms produced similar RR estimates early in the 
pruning process. These findings corresponded to the findings regarding imbalance. 
Finally, in most cases, there was a clear difference between the pre-matched RR estimate 
and the RR estimates early in the pruning process. This difference also corresponded to 
the clear differences in imbalance among the datasets (e.g., compare Figure 11, panel A 






PSM greatly improved covariate balance compared with balance in the pre-matched 
dataset. The points at which our caliper criteria would have been met always were near 
the lowest points on the imbalance trends, indicating that matched datasets constructed 
from these data by many would have corresponded to excellent covariate balance. 
Although imbalance increased with further pruning when the propensity score model was 
based on a higher number of covariates, this phenomenon occurred only after pruning 
more matched sets than would have been required to achieve our caliper criteria. 
Moreover, although MDM led to near-monotonic decreasing imbalance trends, PSM 
achieved better covariate balance with fewer prunings and much larger matched dataset 
sizes for the larger covariate set scenarios.   
 
The fact that the paradox was clearer in the larger covariate set scenarios was not 
surprising. When more covariates are used to build the underlying propensity score 
model, there is a greater probability that different individuals with similar propensity 
score values will have more dissimilar underlying covariate profiles, thus increasing the 
chance that balance will deteriorate after only a few prunings [King and Nielsen, 2016]. 
A similar logic applies to our finding that, in general, more prunings were required to 
achieve the caliper criteria when the underlying propensity score model was based on a 
larger vector of covariates. Even so, matching on the propensity score based on a larger 
vector of covariates always provided a great improvement in covariate balance in the 





We found that manipulation of the index exposure prevalence affected the balancing of 
propensity score distributions more than the balancing of the underlying covariate 
distributions. For both NNM and DGM, the fact that the caliper criteria always were 
achieved with fewer prunings as the index exposure prevalence decreased was not 
surprising when considered from the perspective of balancing propensity score 
distributions. Lower index exposure prevalence equates to a higher probability of a single 
index unit finding a good reference unit match on the propensity score simply because, 
for a given study size, the pool of reference units is relatively larger when the index 
exposure prevalence is lower. However, it was difficult to perceive a clear effect on the 
underlying covariate balance, as evinced by the fact that the imbalance trend shapes did 
not change much as the index exposure prevalence was altered.  
 
For our analyses, the PSM algorithm was not an important indicator of the appearance of 
the paradox, although previous studies comparing NNM with DGM have suggested a 
preference for NNM over DGM with respect to bias [Rassen et al., 2012].  
 
The monotonicity of the MDM trends also was not surprising [King et al., 2011]. The 
failure of MDM to achieve adequate covariate balance early in the pruning process with 
more covariates may be attributed to known issues with MDM [Rubin, 1979; Gu and 
Rosenbaum, 1993; Zhao, 2004; Stuart, 2010]. It has been suggested that higher 
dimensions diminish the efficiency of MDM since, unlike logit-based PSM, MDM 





important. Thus, having more covariates equates to having more complicated interactions 
to balance. This phenomenon may explain our finding that certain covariates were 
balanced differently after MDM compared with NNM and DGM and that the RR 
estimates were usually different for MDM, compared with NNM and DGM, with larger 
covariate sets (Figures 2 and 3; Figures 10 and 11). Thus, PSM may be the better option 
for the high-dimensional matching scenarios that are common to pharmacoepidemiologic 
research.  
 
During matching, only covariate distribution imbalance and study size may be controlled 
directly, although the bias-variance trade-off for effect estimation certainly may be 
affected by the imbalance-study size tradeoff [King et al., 2011]. Thus, it is difficult to 
make strong statements regarding our effect estimate trends. Even so, in general there 
were no large differences between the RR estimates from NNM and DGM early in the 
pruning process, whereas MDM produced clearly different RR estimates when based on 
larger covariate set sizes.  
 
We conclude that in our claims data, PSM in its conventional application would not have 
harmed covariate balance in the manner predicted based on King and Nielsen’s work. 
Although our findings conform to King and Nielsen’s description of the paradox, 
implementing either version of PSM in our datasets with any standard absolute 
propensity score distance caliper resulted in very good balance and preservation of 





either resulted in excellent balance with few prunings or in excellent balance only after 
pruning a very large portion of the matched dataset.   
 
Although we analyzed a limited set of conditions, we focused on data and techniques that 
are common in pharmacoepidemiology. Thus, our results bear important implications for 
applied researchers. Specifically, our results indicate that the paradox might not arise for 
situations in which the pre-matched dataset has high covariate imbalance and in which a 
reasonable absolute propensity score distance caliper is applied. We expect that the 
paradox only should be a practical concern when the pre-matched dataset has very low 
covariate imbalance, such that covariate balance worsens either after the full match, or 
after only a few prunings, as in our simple example; or in the unlikely scenario in which 
pruning is allowed to continue well beyond the point at which a reasonable absolute 
propensity score distance caliper would stop the pruning process, as in our example 
studies. We stress the importance of checking covariate balance after PSM in order to 
identify any increase in covariate imbalance – at the very least, via a univariate 
comparison of the pre- and post-matched covariate distributions. Finally, existing 
algorithms may be used to explore imbalance trends in order to identify disagreements 






CHAPTER 2: EVALUATING THE UTILITY OF COARSENED EXACT MATCHING 




“Coarsened exact matching” (CEM) is a design strategy in cohort studies that has been 
shown to produce good covariate balance between exposure groups and, thus, to reduce 
the impact of confounding bias in observational causal inference [Iacus et al., 2011; Iacus 
et al., 2011]. The strategy is simply matching simultaneously by a set of multivariable 
values for potential confounders (“exact matching”).  Coarsening refers to reducing the 
number of potential matching values for a given variable (e.g., by categorizing 
continuous variables) to increase the number of matches achieved. It has been 
demonstrated that CEM may outperform certain adjustment techniques that are common 
in pharmacoepidemiology with respect to covariate balance and effect bias [King et al., 
2011; King and Nielsen, 2016]. For example, King, et al. [King et al., 2011] and King 
and Nielsen [King and Nielsen, 2016] demonstrated, using real and simulated data, that 
unlike CEM, propensity score matching (PSM) may increase covariate imbalance 
(although this may not apply to the typical pharmacoepidemiologic application of PSM 
[Ripollone et al., 2018]). Since CEM has, to our knowledge, not been implemented 
within the context of pharmacoepidemiologic analyses of claims data, and since CEM has 
been touted to have properties that may make it a preferable choice for causal inference 
[Iacus et al., 2011; Iacus et al., 2011], the utility of CEM for pharmacoepidemiology, 






Here, we compare CEM with 3 techniques for confounding control that have been used in 
pharmacoepidemiologic analyses [Rassen et al., 2012; Desai et al., 2017; Ripollone et al., 
2018]: PSM, Mahalanobis distance matching (MDM) and fine stratification on the 
propensity score (FS).  We present the results of a comparison of these four methods with 
respect to covariate balance, confounding control and effect estimate precision using real 
and simulated claims-based cohorts. We used typical pharmacoepidemiologic claims 
scenarios (i.e., large datasets with a large number of potential confounders of an 
association between a drug and health outcome [Petri and Urquhart, 1991; Patorno et al., 
2013; Patorno et al., 2014]) to enhance the applicability of our results. To our knowledge, 
these techniques have not been compared, simultaneously, with respect to covariate 
balance, confounding control and effect estimate precision within the context of claims-
based analyses, although some separate comparisons have been performed [Iacus et al., 
2011; King et al., 2011; Fullerton et al., 2016; King and Nielsen, 2016; Desai et al., 2017; 
Ripollone et al., 2018].  
 
METHODS 
Here, we describe the mechanics of CEM, PSM, MDM and FS as well as our approach to 
comparing these methods. 
 
Coarsened Exact Matching  
Let X be the vector of observed covariates. CEM entails: (1) coarsening the covariates in 





that similar units are assigned the same value for the coarsened covariate; (2) 
implementing exact matching with the coarsened data – index-exposed and reference-
exposed units (i.e., units with and without the exposure of interest, respectively) that 
appear in the same bin of the multi-way array created by the coarsening strategy are 
considered “exactly-matched”; (3) eliminating units that appear in bins that do not 
contain units of opposite exposure status (i.e., eliminating unmatched units) – such bins 
represent regions of non-positivity that should not contribute to treatment effect estimates 
[Petersen et al., 2012]; (4) estimating the effect of interest in the matched dataset, with 
weights applied to individual units [Iacus et al., 2011; Iacus et al., 2011].  
 
The coarsened boundaries in step 1 should be determined through substantive knowledge. 
However, empirical, “auto-” coarsening methods may be used when substantive 
knowledge is scarce [Iacus et al., 2011; Iacus et al., 2018]. The weighting scheme in step 
4 is critical since unequal numbers of index-exposed and reference-exposed units may 
appear in a given bin, and across bins. Proper weighting is necessary to achieve the 
covariate balance between exposure groups. The scheme used for CEM applies a weight 
of 1 to each index-exposed unit and weights reference-exposed units in each matched set 
in proportion to the distribution of index-exposed units in the matched set. If a higher 
proportion of reference-exposed units, with respect to the number of reference-exposed 
units among all matched sets, appears in the matched set, compared with the equivalent 
proportion of index-exposed units, the reference-exposed units are down-weighted, and 





the proportion of total index-exposed units appearing in the matched set to the equivalent 
proportion of reference-exposed units [Iacus et al., 2011; Iacus et al., 2011]:  
(NIndex-exposed in Matched Set / NTotal Index-exposed) / (NReference-exposed in Matched Set / NTotal Reference-exposed).  
We present a complete derivation of this weight in the Appendix.  
 
With CEM, covariate balance is never worse than the balance in the original dataset 
[Iacus et al., 2011; Iacus et al., 2011; King et al., 2011; King and Nielsen, 2016]. A 
coarsening strategy resulting in more strata will achieve better covariate balance. For 
scalar-based matching techniques, such as PSM and MDM, covariate balance for every 
variable is not necessarily guaranteed. It can be checked after matching, at which point it 
might be decided that the process should be performed again (e.g., using a different 
distance caliper in the matching algorithm) to improve covariate balance. Moreover, 
unlike other techniques, CEM guarantees balance for higher-order terms, such as 
interactions, between exposure groups [Iacus et al., 2011].  
 
Propensity Score Matching 
We focus on the case of 1:1 PSM without replacement, given its popularity in biomedical 
fields such as pharmacoepidemiology [Glynn et al., 2006; Austin, 2008; Austin, 2009; 
Austin and Small, 2014; Wu et al., 2015; Jackson et al., 2017]. PSM entails: (1) for each 
unit, estimating the propensity score: the probability of receiving the index exposure, 
conditional on X, for every unit in a dataset (commonly via logistic regression); (2) 





some algorithm (e.g., nearest neighbor matching [Ho et al., 2018]); (3) pruning from the 
resulting dataset the matched pairs with the largest propensity score distances to eliminate 
poorly-matched units (usually via application of a caliper as part of step 2); (4) 
comparing (usually at the univariate level) pre- and post-matched X distributions to 
assess the improvement in covariate balance and re-running steps 1-3, if necessary; (5) 
estimating the effect of interest in the matched dataset [Austin, 2008; Austin, 2009; 
Austin and Small, 2014; Pan and Bai, 2015; Wu et al., 2015].  
 
The key theoretical benefit of PSM is the ability to match on a scalar summary of X, 
which may involve a large number of variables in a typical claims study [Patorno et al., 
2013; Patorno et al., 2014]. This benefit, along with other benefits that have been outlined 
extensively [Rosenbaum and Rubin, 1983; Austin, 2007; Austin et al., 2007; Austin, 
2008; Austin, 2008; Hade and Lu, 2014; Austin and Schuster, 2016; Ripollone et al., 
2018], may explain the popularity of PSM in pharmacoepidemiology [Rosenbaum and 
Rubin, 1983; Petri and Urquhart, 1991; Glynn et al., 2006; Patorno et al., 2013; Patorno 
et al., 2014; Jackson et al., 2017].  
 
Mahalanobis Distance Matching 
MDM operates similarly to PSM, except that it is based on the Mahalanobis distance, 
which, unlike the distance between propensity scores, is measured in the actual covariate 







where i indexes the exposed unit, j indexes the unexposed unit and Σ is the sample 
covariance matrix of the original data [Iacus et al., 2011; Ripollone et al., 2018]. Similar 
to PSM, the key benefit of MDM is the dimension reduction reflected in a scalar 
summary of X [King et al., 2011; King and Nielsen, 2016; Ripollone et al., 2018].  
 
Fine Stratification on the Propensity Score 
FS is a modification of the normal approach to stratification on the propensity score, 
using a high number (e.g., 50) of propensity score strata [Cochran, 1968; Rosenbaum and 
Rubin, 1984; Desai et al., 2017]. Strata-specific estimates may be pooled, or the same 
weights described for CEM may be applied before effect estimation (i.e., to account for 
the unequal numbers of index-exposed and reference-exposed units within a given 
propensity score stratum, and across propensity score strata). A key benefit of FS, not 
shared by any of the matching techniques, is high retention of study subjects (leading to 
precise effect estimates) in the analytic dataset [Desai et al., 2017]. Only the 
nonoverlapping tails of the PS distribution are dropped from the analysis; within the 
range of overlap, every unit falls into a PS stratum and is counted in the analysis. FS 
overcomes the biggest drawback of matching, which is the exclusion of unmatched units.   
 
Description of Real Datasets  
Two claims cohorts were used. The first was a cohort of 49,919 low-income Medicare 
beneficiaries, at least 65 years of age, who were enrolled in the Pharmaceutical 





who initiated non-selective NSAIDs or selective COX-2 inhibitors (hereafter, “NSAID 
cohort”) [Brookhart et al., 2006; Schneeweiss et al., 2006]. The NSAID cohort was 
previously generated to perform an analysis of the effect of selective COX-2 inhibitors, 
compared with non-selective NSAIDs, on the risk of gastrointestinal complications. 
Approximately 60% of patients represented in this cohort were selective COX-2 inhibitor 
initiators. Approximately 2,000 cases of gastrointestinal complication were observed in 
this cohort. Three covariate sets were used for the NSAID cohort analyses. The “small” 
set comprised 19 continuous and binary covariates that were selected based on clinical 
importance. The second and third covariate sets (“standard” and “large”, respectively) 
comprised binary covariates (representing concomitant medications, comorbidities and 
other medical encounters) selected by a high-dimensional propensity score algorithm 
[Schneeweiss et al., 2009], in addition to the 19 pre-determined covariates: the 50 
covariates with the highest bias-based ranks were included in the standard covariate set, 
and the 100 covariates with the highest bias-based ranks were included in the large 
covariate set. The distribution of the small set of pre-matched covariates in the NSAID 
cohort set is shown in Table 2.  
 
The second cohort comprised information on 886,996 completed pregnancies and was 
generated from the Medicaid Analytic eXtract over the years 2000-2007 (hereafter, 
“statin cohort”) [Huybrechts et al., 2014; Bateman et al., 2015; Desai et al., 2017]. The 
statin cohort was used to perform an analysis of the effect of statin use during the first 





the risk of congenital malformation in the infant. Statin use was defined as the existence 
of at least one claim for a dispensed statin within the first trimester. Approximately 
0.13% of women in this cohort filled a statin prescription during the first trimester. 
Approximately 30,000 congenital malformations were observed in this cohort. The statin 
cohort comprised 20 categorical covariates, which were selected based on clinical 
importance. The distribution of pre-matched covariates in the statin cohort is shown in 
Table 3. 
 
Analysis of Real Datasets  
For each of the 4 real datasets (3 NSAID cohort-based datasets plus the statin cohort), we 
performed CEM, PSM, MDM and FS. For CEM, we applied the R CEM package default 
auto-coarsening strategy, which attempts to divide the range of values for the numerical 
covariates in X into the number of bins required to approximate a normal density 
(Sturges’ rule) [Iacus et al., 2011; Iacus et al., 2018]. For the NSAID cohort PSM and FS 
analyses, all continuous variables were categorized to relax distributional assumptions for 
the propensity score model. For PSM and MDM, we used a nearest neighbor matching 
algorithm. To emulate previous analyses of these data, we applied a 0.025 absolute 
propensity score distance caliper for PSM, but allowed all exposed units to be matched 
for MDM [Ripollone et al., 2018]. We performed MDM for all 3 NSAID cohort-based 
datasets for the sake of example, even though in practice, MDM is not warranted for 
high-dimensional scenarios, where the MDM algorithm is slow to implement and sub-





al., 2011; Ripollone et al., 2018]). Thus, we expected to observe worse covariate balance 
from MDM in the larger NSAID cohort-based analyses. For FS, we trimmed regions of 
non-overlap between exposed and unexposed propensity score distributions and 
generated 50 strata based on quantiles of the exposed propensity score distribution.  
 
We assessed covariate balance in the resulting analytic datasets using the Mahalanobis 
balance metric, which has been used in previous methodological assessments in 
pharmacoepidemiology [Franklin et al., 2014; Ripollone et al., 2018]. The Mahalanobis 
balance is a type of Mahalanobis distance that represents the extent of covariate balance 
in the actual covariate space, and has the following form:  
√[(?̅?T1-?̅?T0)’Σ -1(?̅?T1-?̅?T0)], 
where ?̅?Tk is the vector of covariate means in exposure group k, and Σ is the sample 
covariance matrix of the original data [Gu and Rosenbaum, 1993; Franklin et al., 2014]. 
Higher Mahalanobis balance values indicate worse covariate balance. For the CEM and 
FS scenarios, units were weighted before calculating the Mahalanobis balance.  
 
We then estimated risk ratios and corresponding 95% Wald confidence intervals 
generated from log-binomial regression models. For the NSAID cohort, we estimated the 
risk ratio corresponding to the effect of non-selective NSAIDs, compared with COX-2 
inhibitors, on the risk of gastrointestinal complications. For the statin cohort, we 
estimated the risk ratio corresponding to the effect of statin use during the first trimester 





congenital malformation. For the CEM and FS scenarios, units were weighted before 
calculating the risk ratios and corresponding standard errors.  
 
Description of Simulated Datasets 
A series of plasmode-simulated datasets were generated using the NSAID cohort. In 
plasmode simulation, the true effect of exposure on outcome in a real cohort is set to a 
known value, but the associations within the observed exposure-covariate data from that 
cohort are preserved and are allowed to confound this true effect [Franklin et al., 2014]. 
Plasmode simulation is particularly apt for methodologic research in claims data because 
it maintains observed complex data structures.  
 
Plasmode simulation for a binary outcome scenario entails:  
(1) Regressing outcome on exposure and on the set of desired covariates from the original 
cohort (using a generalized linear model approach) to obtain a set of model parameter 
estimates corresponding to exposure and to each covariate; 
(2) Sampling, with replacement, exposed and unexposed units from the original cohort to 
obtain the desired study size and exposure prevalence, retaining the original exposure-
covariate values for each unit in each sample;  
(3) Altering the model parameter estimate for exposure and intercept from the model in 
step 1 to specify the desired exposure effect and the desired baseline prevalence of 
outcome, respectively, in the sample (the effect strengths of the other covariates from that 





(4) Applying the altered model from step 3 to each sample from step 2 to calculate the 
probability of outcome and, in turn, binary outcome status for each unit. Because of the 
specification of exposure effect, the true desired effect will be reflected in each sample 
[Vaughan et al., 2009; Franklin et al., 2014; Franklin et al., 2015].  
 
Simulation scenarios were constructed by simulating outcome (gastrointestinal 
complications, 20% event rate in all scenarios), using all of the covariates included in a 
given scenario to predict outcome. The true risk ratio for each scenario was set at 1 (ln[1] 
= 0). Each scenario comprised 1,000 simulated cohorts of 25,000 units and represented a 
variation of index exposure prevalence and covariate set size. The index exposure 
prevalence values were 5%, 10%, 20%, 30% and 40% and the covariate set sizes were 
small, standard and large. Two additional small covariate scenarios included a product 
term representing the interaction between continuous age and continuous Charlson 
comorbidity score in the outcome generation model. In one scenario, the coefficient on 
the product term maintained its original estimated value from the real data (“default”). In 
the other scenario, the strength of the product term was increased by 200% 
(“exaggerated”). For both product term scenarios, index exposure prevalence was set at 
20%. We generated product term scenarios because CEM guarantees balance on such 
terms (within the limits of the coarsening strategy), while PSM, FS and MDM do not 
guarantee balance on such terms [Stuart, 2010; Iacus et al., 2011]. We summarize our 






Analysis of Simulated Datasets  
We applied the same methods that were used for the analysis of the real datasets. For the 
scenarios that included a product term between age and Charlson comorbidity score, we 
performed CEM using a manual coarsening strategy for the age and Charlson 
comorbidity score variables to ensure that lack of balance on those variables was not due 
to use of inappropriate coarsening boundaries. Specifically, we coarsened the age 
variable into groups of 5 years, and we coarsened the Charlson comorbidity score 
variable into the following groups: 0, 1, 2, 3, ≥4. We only performed MDM for the small 
covariate set scenarios, for reasons explained above.  
 
We compared the following measures among the methods [Burton et al., 2006]:  
(1) Average proportional decrease in Mahalanobis balance, from the original 
Mahalanobis balance; 
(2) Bias = [average adjusted ln(risk ratio) value] - [true ln(risk ratio)]; 
(3) Variance of the adjusted ln(risk ratio) values; 
(4) Square root of mean squared error (rMSE) = √[bias2 + variance].  
 
RESULTS 
Analysis of Real Datasets 
We present the results of the analysis of real datasets in Table 5. CEM always produced 
essentially perfect covariate balance (Mahalanobis balance values never greater than 





balance, compared with crude balance. MDM was worst with respect to covariate balance 
in each NSAID cohort analysis – with Mahalanobis balance values increasing from 0.207 
to 0.681 (which was worse than the corresponding crude Mahalanobis balance) as 
covariate set size increased. However, for the statin cohort analysis, MDM performed 
better with respect to covariate balance compared with PSM and FS (adjusted 
Mahalanobis balance values: 0.244, 1.632, 0.586, respectively).  
  
CEM always produced the least precise effect estimate (highest 95% confidence interval 
width in each case – even up to 30.58 for the large NSAID cohort analysis). Conversely, 
FS always was optimal with respect to precision (lowest 95% confidence interval width 
in each case). PSM and MDM produced effect estimates with similar levels of precision. 
 
Analysis of Simulated Datasets 
Non Interaction Scenarios 
CEM and FS maintained the highest average proportional decrease in Mahalanobis 
balance among the 4 methods (Figure 12). CEM only performed worse than FS with 
respect to balance improvement in the 5% and 10% index exposure prevalence standard 
and large covariate set scenarios. Generally, PSM performed worst with respect to 
balance improvement in the lowest index exposure prevalence scenarios. For the small 
covariate set scenarios, MDM generally performed worst among the methods with 
respect to balance improvement and produced a consistently decreasing trend in balance 





for CEM, PSM and FS became slightly worse, for a given index exposure prevalence, as 
covariate set size increased. 
 
Perhaps the key finding is that CEM always produced the highest rMSE among the 4 
methods, with the highest values seen in the standard and large covariate set scenarios 
(Figure 13, panels B and C, respectively). In the small covariate set scenarios, the rMSE 
from CEM was highest with 5% index exposure prevalence and generally declined as 
index exposure prevalence increased (Figure 13, panel A). For PSM, MDM and FS, 
rMSE generally decreased as index exposure prevalence increased (Figure 14). For a 
given index exposure prevalence, there was a slight upward trend in rMSE as covariate 
set size increased for all 3 methods. In most scenarios, FS produced the lowest rMSE. 
PSM and FS always produced similar rMSE values for the higher index exposure 
prevalence scenarios, but FS always produced lower rMSE values, compared with PSM, 
in the lower index exposure prevalence scenarios. For the small covariate set scenario, 
MDM always produced the highest rMSE. 
 
It was clear that variance drove the high rMSE values for CEM, since the CEM variance 
trends (Figure 17) were similar to the CEM rMSE trends (Figure 13). The strong 
influence of variance on the rMSE trends also was seen for PSM, FS and MDM, among 
which the FS variance trends were lowest (Figure 18). The CEM bias trends were much 





especially panels B and C). The latter 3 bias trends were relatively similar across all 
scenarios, with PSM and FS yielding the lowest bias values (Figure 16).  
 
Interaction Scenarios 
We display all interaction scenario results in Table 6. The trends among all measures for 
the default and exaggerated scenarios were the same as those seen for the non interaction 
scenarios. There were no substantial differences among the measures comparing the 
default scenario with the exaggerated scenario.  
 
We demonstrate the extent to which CEM improved covariate balance between the index-
exposed and reference-exposed groups within the context of the interaction between age 
and Charlson comorbidity score in Table 7. This table shows the absolute differences 
between the exposure groups with respect to the average of the average age (or weighted 
average age for CEM and FS) within each coarsened category of Charlson comorbidity 
score, and vice versa, across plasmode simulations (default scenario only). CEM yielded 
the lowest difference values among the 4 methods. Unlike the other 3 methods, CEM 
never produced a difference value that was higher than the corresponding difference 
value in the original simulated cohort. Thus, as expected, CEM led to much better 
covariate balance among the coarsened strata of the covariates associated with the 







Overall, the analyses of real and simulated datasets led to the same conclusions. CEM 
was optimal with respect to covariate balance and FS was optimal with respect to bias 
and precision (and still maintained excellent covariate balance). PSM tended to perform 
almost as well as FS with respect to all simulation metrics, especially for higher exposure 
prevalence scenarios. The performance of MDM generally never surpassed that of FS and 
PSM. 
 
The optimal performance of CEM with respect to covariate balance effectively was 
guaranteed by the high number of binary covariates in our data (thus, CEM amounted to 
exact matching) [Iacus et al., 2011; Iacus et al., 2011; King et al., 2011; Fullerton et al., 
2016; King and Nielsen, 2016]. FS performed almost as well as CEM, and better than 
PSM and MDM, with respect to covariate balance. Since 50 strata were used, the 
maximum distance between index-exposed and reference-exposed units within a given 
stratum usually was very low – even lower than the PSM absolute propensity score 
distance caliper of 0.025. The low “implied calipers” associated with FS corresponded to 
high covariate balance overall [5]. Moreover, since it already has been shown that FS 
tends to outperform PSM with rare index exposure prevalence, the differences between 
FS and PSM with respect to covariate balance improvement in the lowest index exposure 
prevalence scenarios were not surprising [Desai et al., 2017]. The fact that PSM, CEM 
and FS generally performed worse with respect to covariate balance improvement, for a 





difficulties of achieving covariate balance in higher dimensions [King et al., 2011; 
Ripollone et al., 2018]. 
 
In the analysis of simulated datasets, the very high rMSE values associated with CEM 
were due to the extreme loss of study size, and the corresponding decrease in the number 
of outcomes, that occurred during creation of the matched datasets. This extreme loss of 
study size may explain the discrepancy between the CEM average proportional decrease 
in Mahalanobis balance trends and the CEM bias trends, which would be expected to 
coincide (i.e., improvement in covariate balance for true confounders should be 
complemented by low bias in the effect estimate). In other words, the decrease in 
effective study size and number of outcomes across simulations was so consequential that 
the resulting sparse data led to elevated bias trends [Greenland et al., 2016]. This extreme 
loss of study size also was clear in the analysis of the real NSAID cohort: in the small 
scenario, the matched dataset produced by CEM comprised 16,139 units and 106 
outcomes, representing a decrease in study size and number of outcomes of 
approximately 70% and 80%, respectively (Table 5). These numbers decreased 
dramatically as covariate set size increased.  
 
The decrease in study size associated with CEM is intuitive since CEM effectively was 
exact matching in our scenarios. This phenomenon also explains the finding that CEM 
performed best with respect to rMSE in the small covariate set scenarios, with higher 





exposed units led to better retention of outcomes and, thus, to lower rMSE. Conversely, 
the large analytic cohorts resulting from FS (leading to low variance) and the consistently 
low bias values associated with FS were responsible for the low rMSE values observed 
for FS. Thus, overall, FS was optimal among the 4 methods with respect to rMSE. 
Notably, PSM performed almost as well as FS with respect to rMSE, increasingly so as 
index exposure prevalence increased – a result also seen in previous work [Desai et al., 
2017]. 
 
The overall suboptimal performance of MDM, especially with respect to covariate 
balance, may be attributed to known issues with MDM [Rubin, 1979; Gu and 
Rosenbaum, 1993; Zhao, 2004; Stuart, 2010; Ripollone et al., 2018]. The fact that 
covariate balance for MDM decreased with higher index exposure prevalence was not 
surprising since no matched set pruning was performed. Thus, overall, with increasing 
index exposure prevalence, the matched dataset’s Mahalanobis balance value approached 
the original dataset’s Mahalanobis balance value. A similar logic applies to the 
decreasing bias trend for MDM: overall, since bias already was relatively low in the 
original dataset, the bias from MDM approached the bias from the original dataset as 
index exposure prevalence increased (Web Figure 2, panel A). It is worth noting that 
MDM performed almost as well as PSM with respect to variance, mainly because of the 
lack of matched set pruning for MDM.  
 





ultimate objective is to obtain a valid and precise effect estimate. The high levels of 
balance achieved by CEM in our study were not complemented by low rMSE values 
because CEM produced heavy losses in study size (and numbers of outcomes) to achieve 
this balance. If not for this problem, there would be less motivation to pursue a dimension 
reduction technique, such as a propensity score-based method. Therefore, in these types 
of pharmacoepidemiologic analyses, CEM may not be the optimal choice, especially if 
the vector of important confounders is large. Instead, FS may be optimal with respect to 
confounding control and effect estimate precision. PSM may perform similarly to FS, 
especially if index exposure prevalence is high. 
 
Our simulation study had some noteworthy limitations. Although we covered a wide 
range of scenarios (by varying index exposure prevalence and covariate set size), the 
simulated data were based on only one real cohort, exemplifying only one type of 
complex pharmacoepidemiologic claims exposure-covariate structure. The statin cohort, 
for example, also could have been used (although we note that the NSAID cohort allowed 
us more flexibility in terms of covariate set size variation). Also, we only implemented 
the 4 methods in the common manner (e.g., auto-coarsening strategy for CEM, use of a 
0.025 absolute propensity score distance caliper for PSM, etc.), not necessarily in an 





CHAPTER 3: ACCOUNTING FOR SAMPLING VARIABILITY IN EFFECT 
ESTIMATION AFTER 1:1 PROPENSITY SCORE MATCHING WITHOUT 
REPLACEMENT: A REVIEW OF THEORY AND METHODS 
 
INTRODUCTION 
The conventional approach to estimating the standard error of the effect estimate in 
propensity score analysis does not specifically account for the sampling variability 
associated with propensity score estimation [McCandless et al., 2009; Alvarez and Levin, 
2014; Austin and Small, 2014; Pan and Bai, 2015]. This approach is common for 
propensity score matching (PSM), the most popular propensity score technique [Morgan 
and Winship, 2007; Pearl, 2010; Pan and Bai, 2015]. Generally, in PSM, only the 
variability directly associated with effect estimation is considered in the standard error of 
the effect estimate, leaving the impact of sampling variability on the actual propensity 
score estimation process unaccounted. This practice may lead to inaccurate estimation of 
the standard error of the effect estimate [Alvarez and Levin, 2014; Austin and Small, 
2014; Abadie and Imbens, 2016].   
 
Since Rubin and Thomas first highlighted unique characteristics of variance in PSM 
[Rubin and Thomas, 1992; Rubin and Thomas, 1996], the pool of literature on handling 
sampling variability in PSM has grown. However, it is difficult to find a straightforward 
depiction of how the sampling variability associated with propensity score estimation 
manifests in PSM. In light of the popularity of PSM, we sought to provide this depiction 
as well as an explanation of methods that may account for this sampling variability better 





We focus on the case of 1:1 PSM without replacement (hereafter, “1:1 PSM”) since it is a 
popular PSM approach in biomedical fields, such as pharmacoepidemiology [Glynn et 
al., 2006; Austin, 2008; Austin, 2008; Austin, 2009; Austin and Small, 2014; Wu et al., 
2015; Jackson et al., 2017]. For our explanation of sampling variability in 1:1 PSM, we 
assume use of a deterministic matching algorithm (i.e., one that always produces the 
same matches, for the same pre-matched sample, based on closest propensity score 
distance between an exposed unit and an unexposed unit) for the sake of simplicity 
[Rassen et al., 2012]. We summarize the main facets of bootstrap and Bayesian methods 
that attempt to account for this sampling variability and we illustrate the use of these 
methods using a real pharmacoepidemiologic claims-based study [Tu and Zhou, 2002; 
McCandless et al., 2009; Kaplan and Chen, 2012; Austin and Small, 2014; Pan and Bai, 
2015].  
 
Although not the focus of our review, the variability associated with propensity score 
estimation also affects standard error estimation in other types of propensity score 
analysis (e.g., stratification by propensity score, inverse weighting by propensity score) 
and that methods to address this issue for these other types of analyses exist as well 
[Hirano et al., 2003; Lunceford and Davidian, 2004; Li and Greene, 2013; Li et al., 
2017]. These other types of propensity score analysis (notably, stratification by 
propensity score) may be preferable to 1:1 PSM with respect to overall efficiency. We 
focused on 1:1 PSM due to its frequent use in pharmacoepidemiology [Rosenbaum and 





SAMPLING VARIABILITY IN 1:1 PSM 
Figure 19 demonstrates the conventional application of 1:1 PSM using 10 units (5 
exposed, 5 unexposed). We use 10 units only for demonstration purposes, and we can 
assume that these units come from a larger population. From the 10-unit population, we 
demonstrate the derivation of 6 matched sets. In the 10-unit population, each numbered 
exposed unit has exactly the same true propensity score as its corresponding unexposed 
unit (i.e., exposed unit 1 and unexposed unit 1 have exactly the same true propensity 
score, etc.). Moreover, each of the 5 exposed-unexposed pairs has a unique, true 
propensity score.   
 
By calculating the conventional standard error (e.g., the standard error of a risk ratio from 
a log binomial regression model), the analyst implicitly assumes that the effect estimate is 
generated from a direct “random” sample of the population. Thus, the matched sets are 
considered direct “random” samples of the population, as shown in Figure 19. However, 
the pre-matched samples (i.e., the original dataset for a given study), not the matched 
sets, are directly derived from the population. Therefore, sampling variability in 1:1 PSM 
first affects the selection of pre-matched samples and influences not only effect 
estimation but also the intermediate step of propensity score estimation.  
 
In addition to the population and matched sets, Figure 20 displays the corresponding pre-
matched samples, each of which is unique and, thus, is expected to result in different 





score estimation in 1:1 PSM can be demonstrated using exposed unit 1, which appears in 
all 6 pre-matched samples and corresponding matched sets.   
 
Pre-matched Sample 1: Exposed unit 1 and unexposed unit 1 receive their true propensity 
scores as their propensity score estimates and no other unexposed unit receives this 
propensity score estimate. Consequently, unexposed unit 1 is guaranteed to be matched to 
exposed unit 1.  
 
Pre-matched Sample 2: Exposed unit 1 receives its true propensity score as its propensity 
score estimate, but unexposed unit 1 does not receive its true propensity score as its 
propensity score estimate. Unexposed unit 2 is matched to exposed unit 1 because its 
propensity score estimate is closest to exposed unit 1’s propensity score estimate.  
 
It is possible for exposed unit 1 to receive its true propensity score as its propensity score 
estimate, but for unexposed unit 1 not to receive its true propensity score as its propensity 
score estimate if, for example, exposed unit 1 and unexposed unit 1 have different 
covariate values underlying their shared, true propensity score value (i.e., even though 
unexposed unit 1 and exposed unit 1 have the same true propensity score, the underlying 
covariate profiles still may differ between the two units [Rosenbaum and Rubin, 1983]). 
During propensity score estimation, a binary covariate may receive an inaccurate 
coefficient estimate, which may cause units that have a specific value for this binary 





Pre-matched Sample 3: Exposed unit 1 does not receive its true propensity score as its 
propensity score estimate, but unexposed unit 1 does receive its true propensity score as 
its propensity score estimate (this is the opposite of what was seen in pre-matched sample 
2). Unexposed unit 5 is matched to exposed unit 1 because its propensity score estimate is 
closest to that of exposed unit 1’s propensity score estimate.  
  
Pre-matched Sample 4: Unexposed unit 1 is not in this pre-matched sample. Even if 
exposed unit 1 receives its true propensity score as its propensity score estimate, it cannot 
be matched to unexposed unit 1.  
 
Pre-matched Sample 5: As in the first matched set, exposed unit 1 and unexposed unit 1 
receive their true propensity scores as their propensity score estimates and are matched. 
However, unlike pre-matched sample 1, pre-matched sample 5 comprises exposed unit 5 
and unexposed unit 5, making the resulting matched set distinct from matched set 1.  
 
Pre-matched Sample 6: Although the sixth matched set is exactly the same as the first 
matched set, pre-matched sample 6 is not the same as the pre-matched sample 1. 
Sampling variability still is evident in the propensity score estimates (i.e., the propensity 
score estimates are slightly different because pre-matched sample 6 is different from pre-
matched sample 1), even though the matching decisions are not different from those seen 






Thus, different pre-matched samples may result in different propensity score estimates 
for the same units and, consequently, in different matching decisions for those units. 
Moreover, the matched set may not include certain units, either because they were not 
matched or because they were not in the pre-matched sample. The key point is that the 
exposure model generated in each pre-matched sample is an estimate of the true 
population exposure model and, thus, is a manifestation of sampling variability. This 
manifestation of sampling variability is not necessarily represented in the standard error 
of the effect estimate from a conventional 1:1 PSM analysis.  
 
Our depiction of sampling variability in 1:1 PSM is relevant for other types of propensity 
score analysis as well. For example, if stratification by propensity score was applied in 
our depiction instead, the strata in which exposed unit 1 would appear (i.e., in the final 
analytic dataset) may have comprised different exposed and unexposed units, depending 
on the composition of the corresponding original dataset (i.e., the dataset that was 
sampled from the population, before any stratification).  
 
 
METHODS TO ACCOUNT FOR SAMPLING VARIABILITY IN 1:1 PSM 
Bootstrap and Bayesian techniques have been shown to accurately estimate the standard 
error of an effect estimate from 1:1 PSM without replacement. We describe the methods 





standard error of the effect estimate for the specific case of 1:1 PSM without 
replacement.  
 
Bootstrap 1:1 PSM 
Use of the bootstrap for standard error estimation (especially when the observed data are 
not associated with a known probability distribution) is an established statistical practice 
[Efron, 1979; Efron and Tibshirani, 1986]. It has been suggested that bootstrap 
procedures are ideal for propensity score analysis since these procedures provide non-
parametric, robust statistics for complex distributions, such as the distribution of 
propensity scores [Guo and Fraser, 2010; Bai, 2013; Austin and Small, 2014]. To this 
end, Austin and Small [Austin and Small, 2014] described and evaluated the “simple 
bootstrap” and the “complex bootstrap”. It is worth noting that other bootstrap methods 
for propensity score matching, such as the “wild bootstrap”, have been developed, but 
that these methods are ideal only for the case of PSM with replacement and, thus, were 
not addressed here [Otsu and Rai, 2017; Bodory et al., 2018]. 
  
 
Simple Bootstrap 1:1 PSM 
Simple bootstrap 1:1 PSM is performed by applying the standard bootstrap to the 
propensity score-matched set [Austin and Small, 2014]. The bootstrap sample is 
generated by sampling matched pairs (as opposed to individual units) from the propensity 





as the size of the propensity score-matched set. Thus, if the propensity score-matched set 
comprises N matched pairs, the bootstrap sample also will comprise N matched pairs. M 
such bootstrap samples are drawn and the relevant effect is estimated using each of the M 
bootstrap samples. The standard deviation of the estimated effects across the M samples 
is used as an estimate of the standard error of the effect estimate derived from the original 
propensity score-matched set. We depict the mechanics of simple bootstrap 1:1 PSM in 
Figure 21.  
 
Complex Bootstrap 1:1 PSM 
In complex bootstrap 1:1 PSM, M standard bootstrap samples are generated by sampling 
individual units from the pre-matched sample, with replacement. In each of the M 
samples, 1:1 PSM is performed and the relevant effect is estimated. The standard 
deviation of the estimated effects across the M samples is used as an estimate of the 
standard error of the effect estimate derived from the original matched sample. Since the 
bootstrap procedure is based on the pre-matched sample (not on matched pairs from the 
matched set), the M samples may have varying numbers of matched pairs. Although, in 
their simulation study, Austin and Small [Austin and Small, 2014] demonstrated a slight 
advantage for standard error estimation by simple bootstrap 1:1 PSM over complex 
bootstrap 1:1 PSM, we included complex bootstrap 1:1 PSM in our review because, 
unlike for simple bootstrap 1:1 PSM, its sampling scheme directly accounts for the 
potential variation due to propensity score matching (i.e., by repeatedly performing 1:1 





Bayesian 1:1 PSM 
A key benefit of Bayesian methodology is the ability to incorporate prior information 
(“beliefs”) regarding a parameter of interest (usually a measure of effect, such as the risk 
ratio, in epidemiology) into the analysis of the data. The incorporation of prior 
information into the analysis of the data leads to a “posterior” distribution on which final 
estimates of the parameter of interest are based. We direct the reader who is unfamiliar 
with Bayesian methodology to the introductory literature regarding Bayesian statistics for 
epidemiology, especially Spiegelhalter, et al. [Spiegelhalter et al., 2004], Greenland 
[Greenland, 2006; Greenland, 2007; Greenland, 2009] and MacLehose [MacLehose, 
2014].  
 
Although propensity score analysis generally is performed within the context of 
frequentist statistics, there is a growing literature on Bayesian applications in propensity 
score analysis [Zigler, 2016]. Much of this work has addressed incorporation of the 
sampling variability associated with propensity score estimation into the final effect 
estimate using prior information to generate posterior distributions for the propensity 
score model parameters [Hoshino, 2008; McCandless et al., 2009; An, 2010; Kaplan and 
Chen, 2012; Kaplan and Chen, 2014]. This Bayesian approach (hereafter, “BPSM”; 
described by An [An, 2010] and Kaplan and Chen [Kaplan and Chen, 2012; Alvarez and 
Levin, 2014]) can produce accurate standard error estimates for the case of 1:1 PSM. 






(1) Estimate the propensity score model using a Markov-chain Monte Carlo (MCMC) 
methodology. MCMC methods are simulation techniques, commonly used in Bayesian 
analyses, that can generate a sample from the posterior distribution without a specific 
algebraic form for that distribution [Spiegelhalter et al., 2004]. The posterior distribution 
summarizes the remaining uncertainty in the parameter, after accounting for the prior 
information and the data. For BPSM, a MCMC-based logistic regression modeling 
procedure may be used to generate a sample from the joint posterior distribution for the 
propensity score model parameters (the intercept and vector of slopes). The size of the 
posterior distribution sample for these parameters corresponds to the number of 
simulations saved from the MCMC process [Kaplan and Chen, 2012]. Thus, if the 
MCMC process contributes N simulations to the posterior distribution, there will be N 
different propensity score models (N sets of intercept and slope values).  
(2) Apply each of the N different MCMC-based propensity score models from step 1 to 
the original data to create N different sets of propensity score estimates. This step 
effectively creates a posterior distribution for the propensity score estimates for each unit 
that accounts for the uncertainty in estimation of the propensity score model. 
(3) Perform 1:1 PSM on the original data using each of the N sets of propensity score 
estimates from step 2, resulting in N different matched sets. The N matched sets are 
created independently, so they may have varying numbers of matched pairs. 
(4) Generate effect and standard error estimates for each of the N matched datasets from 
step 3 using a standard frequentist approach (e.g., a log binomial outcome model for the 





(5) Use the average of the N effect estimates as the final effect estimate. 
(6) Apply a formula for estimating the standard error of the effect estimate that is based 
on the law of total variance, as described by Kaplan and Chen [Kaplan and Chen, 2012]. 
We depict the mechanics of complex bootstrap 1:1 PSM in Figure 23.  
 
A “full Bayesian” approach, in which the outcome model also is estimated from the 
matched dataset via an MCMC method (incorporating a prior distribution for the outcome 
model in step 4), also could be used [Kaplan and Chen, 2012]. However, Kaplan and 
Chen [Kaplan and Chen, 2012] indicate that such an approach may lead to standard errors 
that are less accurate than the standard errors from the BPSM approach.  
 
Empirical Example 
Description of Dataset 
We used a cohort of 49,919 low-income Medicare beneficiaries, at least 65 years of age, 
who were enrolled in the Pharmaceutical Assistance Contract for the Elderly database in 
New Jersey over the years 1999-2002 and who initiated non-selective NSAIDs or 
selective COX-2 inhibitors  [Brookhart et al., 2006; Schneeweiss et al., 2006]. This 
cohort was generated to perform an analysis of the effect of selective COX-2 inhibitors, 
compared with non-selective NSAIDs, on the risk of gastrointestinal complications. 
Approximately 60% of patients represented in this cohort were selective COX-2 inhibitor 
initiators. Approximately 2,000 cases of gastrointestinal complication were observed. 





clinical importance as well as 50 binary covariates (representing concomitant 
medications, comorbidities and other medical encounters) selected by a high-dimensional 
propensity score (HDPS) algorithm [Schneeweiss et al., 2009]. The distribution of the 
pre-matched non-HDPS covariates is shown in Table 2.  
 
Analyses 
We applied the following 1:1 PSM techniques, generating risk ratio estimates (in this 
case, corresponding to the effect of non-selective NSAIDs, compared with COX-2 
inhibitors, on the risk of gastrointestinal complications) and corresponding standard 
errors (and Wald 95% confidence intervals). To emulate previous analyses of these data, 
1:1 PSM was performed with a nearest neighbor matching algorithm and a 0.025 absolute 
propensity score distance caliper [Ripollone et al., 2018]. Risk ratios were estimated 
using log binomial regression, unless otherwise noted.  
 
(1) Conventional 1:1 PSM. Two models were generated. One model was based on 
maximum likelihood estimation, yielding the conventional standard error estimate. The 
other model was based on generalized estimating equations (GEE), yielding a robust 
standard error estimate designed to account for matched set correlation. We generated the 
second model since it has been demonstrated that this approach may lead to a better 
approximation of the sampling distribution of the effect estimate from a propensity score 
matched dataset compared with the approach that ignores matched set correlation 





Additionally, we calculated a standard error estimate using a simple contingency table-
based formula that accounts for 1:1 matching [Rothman, 1986] so that we could compare 
the results of the model-based approaches to the results of the simplest possible approach 
for a matched cohort analysis. Letting the number of matched pairs for which the exposed 
unit and the unexposed unit experienced the outcome, for which only the exposed unit 
experienced the outcome, for which only the unexposed unit experienced the outcome 
and for which neither unit experienced the outcome be f11, f10, f01 and f00, respectively, 
the formula for the standard error of the risk ratio is:  
√[(f10 + f01) / ((f11 + f10)*(f11 + f01))]. 
For this simple approach, the risk ratio was generated via the corresponding contingency 
table-based formula [Rothman, 1986]:  
(f11 + f10) / (f11 + f01) 
(2) Simple bootstrap 1:1 PSM. 1,000 bootstrap samples were generated. 
(3) Complex bootstrap 1:1 PSM. 1,000 bootstrap samples were generated. 
(4) BPSM. To emulate the approach taken by Kaplan and Chen [Kaplan and Chen, 2012], 
we generated a MCMC-based logistic regression (using the “MCMClogit” function in the 
R package, “MCMCpack”) model to estimate propensity scores. We used a non-
informative uniform prior for the intercept parameter (i.e., a prior that has minimal 
influence on the estimation of the intercept parameter in the propensity score model) and 
the same independent normal prior for each slope (i.e., one corresponding to each 
covariate in dataset). The independent normal prior always had a mean of zero, but its 





Specifically, the variance was set at 0, 1, 1/10 and 1/100 (with lower values indicating 
more precise prior distributions). The MCMC procedure generated a total of 10,000 
simulations (after 1,000 burn-in iterations). A thinning interval of 10 was applied after 
the burn-in to reduce the potential impact of auto-correlation among the simulations. 




We display the results of the empirical example analyses in Table 8. It was clear that, 
overall, the standard error estimates were similar among all methods. The non-Bayesian 
techniques always produced the largest standard error values (with the highest value seen 
in the simple bootstrap analysis: 0.111). BPSM produced very similar standard error 
estimates (each approximately 0.104). Thus, the different prior variance values for the 
MCMC-based propensity score model did not noticeably impact the precision of the final 
effect estimate. It did, however, impact the exposure effect estimate, with more precision 
in the prior distribution corresponding to estimated risk ratios closer to null. All risk ratio 
estimates from BPSM were closer to the null than were the adjusted risk ratio estimates 
from the non-Bayesian techniques (which were effectively the same).  
 
Discussion 
The results of our empirical example indicate that for our dataset, standard error estimates 





associated with propensity score estimation did not result in standard error estimates that 
were much different from the standard error estimate from the conventional application 
of 1:1 PSM.  
 
The fact that the standard error estimates from the bootstrap techniques were similar to 
the standard error estimates from the conventional techniques is not surprising in light of 
the results of the simulation study conducted by Austin and Small [Austin and Small, 
2014], and the results of an ongoing simulation study of the comparative performance of 
bootstrap procedures for 1:1 PSM similar to those demonstrated here using datasets 
similar to our example dataset with respect to size and number of covariates  [Desai et al., 
2019].   
 
In their simulation study, Austin and Small [Austin and Small, 2014] demonstrated that 
the mean ratio of estimated standard error to the standard deviation of simulated exposure 
effects tended to be smaller for simple bootstrap 1:1 PSM, and closer to the value from 
the scenario accounting for matched pair correlation (as in our example), than for 
complex bootstrap 1:1 PSM. The authors noted that this finding might make simple 
bootstrap 1:1 PSM preferable to complex bootstrap 1:1 PSM in practice. They concluded 
that a method for estimating the standard error of the effect estimate that accounts for 
matched pair correlation may be best in most applications (even though such a method 
also treats the propensity score as a fixed quantity, rather than an estimate that also is 





rare case in which a parametric estimator for the standard error is unavailable (i.e., in a 
scenario that relies on a more complex PSM approach such as “double propensity score 
matching” [Austin, 2017]) [Austin and Small, 2014]. However, the preference for a 
method that accounts for matched pair correlation would seem to have made no 
difference in our data, given the similarity of the results between the robust log binomial 
model and the maximum likelihood-based log binomial.  
 
The variance of the prior distribution for the propensity score model in our BPSM 
analyses had no notable influence on the standard error estimate. The fact that the 
standard error estimates from BPSM always were slightly smaller than the standard error 
estimates from the non-Bayesian approaches was surprising in light of the results of the 
simulation analysis performed by Kaplan and Chen [Kaplan and Chen, 2012], which 
indicated that BPSM tended to yield larger and more accurate standard error estimates 
compared with the standard error estimates from the conventional PSM approach. 
However, the simulated datasets in the Kaplan and Chen study were much smaller and 
comprised far fewer covariates (with scenarios using no more than 300 units and 3 
covariates) than what would typically be encountered in pharmacoepidemiology [Patorno 
et al., 2013; Patorno et al., 2014]. Moreover, Kaplan and Chen note that BPSM may be 
preferable for such small-data scenarios. The preference for small-data scenarios might 
also explain why the risk ratio estimates from BPSM in our example were so different 
from the risk ratio estimates from the non-Bayesian results (although we note again that, 





involved averaging over effect estimates based on the MCMC posterior distribution). 
Thus, it is unclear how applicable the previous simulation findings are to typical claims 
scenarios.  
 
A key point to consider is that it is difficult to predict whether incorporation of the 
variability in propensity score estimation into the standard error estimate from 1:1 PSM 
will lead to a higher (which may be the intuitive prediction, and which was seen in the 
BPSM analysis) or lower standard error estimates. This is the case because of the general 
complexity of the sampling distribution of effect estimates in PSM and because matching 
on the estimated propensity score may be more statistically efficient (leading to lower 
standard errors) than matching on the true propensity score [Austin and Small, 2014; 
Abadie and Imbens, 2016]. Since one cannot know whether the estimated propensity 
scores for the pre-matched sample actually are the true propensity scores for the pre-
matched sample, one cannot predict how large the standard error estimates will be, even 
with methods that incorporate the uncertainty due to propensity score estimation in 1:1 
PSM.     
 
Our review provides an accessible depiction of sampling variability for the specific case 
of 1:1 PSM without replacement as well as the methods that attempt to account for this 
sampling variability. Our example scenario indicates that these methods may not produce 
appreciably different standard errors, compared with conventional 1:1 PSM methods, for 





assessing the standard error estimate (e.g., use of the simple, contingency table-based 
formula) might be the best approach in these cases. However, additional simulation 
studies might be warranted to confirm these findings. Specifically, even though our 
results conform with the findings of previous simulation studies of the bootstrap 
techniques, more work may be required to determine the utility of BPSM for the typical 


















Male     
  White 1 2 3 0.3 
  Not white 1 2 3 0.3 
Female      
  White 1 2 3 0.3 
  Not white 1 2 3 0.3 
Abbreviations: PS = Propensity Score 
a The population represented in this table contains index and reference exposure groups that are perfectly balanced on sex and race. The 
propensity score values for all 12 units are equal. 1:1 propensity score matching without replacement would be expected to increase the 








Table 2. Example Distributions of the Non-High Dimensional Propensity Score Covariates in the Pre-matched Pharmaceutical 
Assistance Contract for the Elderly (1999-2002), Standard Covariate Set, Original Index Exposure Prevalence Dataset and in 
the Three Corresponding Fully-matched Datasets 
Covariate 
Pre-matched (n = 49,653) Full, NNM  Full, DGM  Full, MDM  
Non-selective 
NSAIDs  
(n = 17,611)a 
Selective COX-2 
Inhibitors  
(n = 32,042) 
Selective COX-2 
Inhibitors  
(n = 17,611) 
Selective COX-2 
Inhibitors  
(n = 17,611) 
Selective COX-2 
Inhibitors  
(n = 17,611) 
Mean (SD) % Mean (SD) % Mean (SD) % Mean (SD) % Mean (SD) % 
Age  77.79 (7.30)  79.76 (7.24)  78.15 (7.24)  78.16 (7.23)  78.95 (7.06)  
Generics  7.43 (5.02)  8.41 (5.25)  7.56 (5.02)  7.60 (5.03)  6.75 (4.17)  
Any Medical Visit  7.74 (6.61)  8.60 (6.67)  7.86 (6.53)  7.90 (6.59)  6.96 (5.32)  
Charlson Comorbidity  1.85 (1.97)  2.05 (2.01)  1.85 (1.95)  1.87 (1.96)  1.47 (1.58)  
Male   18.84  14.09  17.47  17.50  13.43 
Race           
  White   89.76  95.45  92.94  92.86  94.61 
  Black   8.97  3.54  5.91  5.96  4.15 
  Other   1.27  1.02  1.15  1.19  1.24 
Comorbidities           
  Bleeding  1.11  1.72  1.15  1.25  1.08 
  CHF   24.58  30.36  24.76  25.17  18.80 
  Coronary Disease  14.78  16.43  14.89  14.87  9.60 
  Hypertension  70.20  72.82  70.18  70.29  70.82 
  Rheumatoid Arthritis  2.70  5.00  3.02  2.84  2.54 
  Osteoarthritis  33.49  48.53  35.16  35.01  41.23 
  Ulcer  2.42  3.71  2.58  2.58  2.14 
Hospitalization in Prior Year  26.07  30.60  26.47  26.90  17.86 
Nursing Home Resident  5.66  8.34  6.18  6.23  3.64 
Other Medications           








Pre-matched (n = 49,653) Full, NNM  Full, DGM  Full, MDM  
Non-selective 
NSAIDs  
(n = 17,611)a 
Selective COX-2 
Inhibitors  
(n = 32,042) 
Selective COX-2 
Inhibitors  
(n = 17,611) 
Selective COX-2 
Inhibitors  
(n = 17,611) 
Selective COX-2 
Inhibitors  
(n = 17,611) 
Mean (SD) % Mean (SD) % Mean (SD) % Mean (SD) % Mean (SD) % 
  Other Gastrointestinal 
Medication 
 20.44  27.42  21.70  21.75  20.28 
  Warfarin   6.55  13.27  7.00  7.02  5.95 
Year of Exposure Initiation           
  1999  48.79  41.68  47.09  47.11  43.21 
  2000  23.91  29.94  24.90  24.79  29.10 
  2001  20.00  21.28  20.49  20.73  21.08 
  2002  7.30  7.09  7.52  7.38  6.62 
Abbreviations: DGM = Propensity score digit-based greedy Matching; MDM = Mahalanobis distance matching; NNM = Propensity score 
nearest neighbor matching 








Table 3. Example Distributions (%) of all Covariates in the Pre-matched Medicaid Analytic eXtract (United States, 2000-
2007), Original Index Exposure Prevalence Dataset and in the Three Corresponding Fully-matched Datasets 
Covariate 
Pre-matched (n = 886,996) Full, NNM  Full, DGM  Full, MDM  
Statins  
(n = 1,152)a 
No Statins  
(n = 885,844) 
No Statins  
(n = 1,152) 
No Statins  
(n = 1,152) 
No Statins  
(n = 1,152) 
Age Categories      
  ≤ 19 5.56 29.43 5.21 4.25 5.21 
  20–24 14.06 35.6 12.76 14.41 14.24 
  25–29 21.09 20.41 21.96 22.31 22.74 
  30–34 28.13 9.48 28.91 28.65 27.34 
  35–39 22.22 4.17 21.96 21.61 21.53 
  ≥ 40 8.94 0.91 9.20 8.77 8.94 
Race      
  Asian/Other Pacific Islander 6.51 3.42 6.42 5.90 5.38 
  Black/African American 25.69 34.09 22.92 24.31 27.95 
  Hispanic/Latino 17.10 15.08 21.09 17.88 17.88 
  Other 5.73 4.74 6.08 7.47 4.86 
  Unknown 2.95 2.01 3.39 3.21 2.78 
  White 42.01 40.67 40.10 41.23 41.15 
U.S. Region      
  Midwest 23.18 32.02 22.48 20.92 24.39 
  Northeast 21.27 14.97 20.57 22.83 18.75 
  South 26.04 26.07 24.13 26.13 26.48 
  West 29.51 26.94 32.81 30.12 30.38 
Number of Non-antihypertensive 
Generics Used 
     
  None 8.33 46.45 6.25 7.29 10.76 
  1–3 27.00 36.64 30.30 28.39 28.21 








Pre-matched (n = 886,996) Full, NNM  Full, DGM  Full, MDM  
Statins  
(n = 1,152)a 
No Statins  
(n = 885,844) 
No Statins  
(n = 1,152) 
No Statins  
(n = 1,152) 
No Statins  
(n = 1,152) 
Number of Physician Visits During 
the Pre-index Period 
     
  None 27.08 52.07 25.78 25.52 25.87 
  1–3 49.91 39.52 51.82 51.48 53.39 
  > 3 23.00 8.41 22.40 23.00 20.75 
Year of Delivery      
  2000 0.00 0.14 0.00 0.00 0.00 
  2001 4.17 9.65 4.51 4.25 3.39 
  2002 5.56 11.04 6.34 4.77 6.34 
  2003 10.42 14.59 10.33 9.72 10.33 
  2004 19.10 17.61 18.23 18.92 17.36 
  2005 20.14 16.88 20.23 20.23 20.31 
  2006 23.78 17.49 21.18 24.05 24.74 
  2007 16.84 12.60 19.18 18.06 17.53 
Comorbidities      
  Hypertension 40.63 5.00 39.76 40.97 40.02 
  Diabetes 45.14 3.06 40.71 41.75 45.14 
  Renal Disease 4.17 0.46 3.91 3.82 4.17 
  Obesity 23.35 5.31 23.87 25.26 23.35 
  Tobacco Use 11.02 7.77 10.16 11.11 8.85 
  Alcohol Abuse 3.99 2.61 4.60 4.69 3.13 
  Illicit Drug Use 6.42 5.33 6.60 6.68 5.38 
  Dyslipidemia 67.10 3.14 71.09 71.53 66.58 
Multiple Gestation 6.60 3.55 6.16 7.03 5.64 
Multipara 88.80 75.69 88.02 88.54 92.01 
Other Medications      








Pre-matched (n = 886,996) Full, NNM  Full, DGM  Full, MDM  
Statins  
(n = 1,152)a 
No Statins  
(n = 885,844) 
No Statins  
(n = 1,152) 
No Statins  
(n = 1,152) 
No Statins  
(n = 1,152) 
  Antidiabetic 38.80 1.27 33.94 34.29 38.80 
  Hypertension Medication 53.73 6.65 52.52 50.95 52.78 
  Potentially Teratogenic Medication 31.68 3.63 29.08 28.47 30.30 
Abbreviations: DGM = Propensity score digit-based greedy Matching; MDM = Mahalanobis distance matching; NNM = Propensity score 
nearest neighbor matching 







Table 4. Summary of Plasmode Simulation Scenarios 
Exposure Prevalencea Covariate Setb Product Termc Estimate Strength 
0.05 Small — 
 Standard — 
 Large — 
0.10 Small — 
 Standard — 
 Large — 
0.20 Small — 
  Default 
  Exaggerated 
 Standard — 
 Large — 
0.30 Small — 
 Standard — 
 Large — 
0.40 Small — 
 Standard — 
 Large — 
a All plasmode scenarios were based on the NSAID cohort. 
b The “Small” set comprised 19 pre-determined covariates; the “Standard” and 
“Large” sets comprised an additional 50 and 100 covariates, respectively, 
selected from a high-dimensional propensity score algorithm. 
c The product term represented the interaction between age and Charlson 
comorbidity score. The “default” scenario maintained the original product term 
and the “exaggerated” scenario was based on a product term that was 200% 









Table 5. Real Dataset Analysis Results   




RR 95% CI 95% CI Widtha MB 
NSAID, Small Crude 49,653 552 0.92 — — 0.558 
 CEM 16,139 106 1.68 [1.09, 2.58] 2.36 0.017 
 PSM 34,150 355 1.05 [0.86, 1.29] 1.51 0.089 
 MDM 35,222 361 1.05 [0.86, 1.29] 1.51 0.207 
 FS 49,634 552 1.08 [0.90, 1.31] 1.45 0.026 
NSAID, Standard Crude 49,653 552 0.92 — — 0.641 
 CEM 3,226 10 2.55 [0.64, 10.09] 15.73 0.014 
 PSM 33,368 339 1.12 [0.90, 1.38] 1.53 0.087 
 MDM 35,222 318 1.39 [1.11, 1.74] 1.56 0.541 
 FS 49,626 552 1.12 [0.93, 1.36] 1.47 0.051 
NSAID, Large Crude 49,653 552 0.92 — — 0.654 
 CEM 1,763 6 1.71 [0.31, 9.48] 30.58 0.020 
 PSM 33,174 340 1.09 [0.88, 1.34] 1.53 0.089 
 MDM 35,222 309 1.49 [1.19, 1.87] 1.57 0.681 
 FS 49,626 552 1.12 [0.92, 1.37] 1.48 0.057 
Statin Crude 886,996 31,489 1.79 — — 5.127 
 CEM 11,321 307 1.13 [0.54, 2.36] 4.35 0.000 
 PSM 2,302 144 1.03 [0.75, 1.41] 1.88 1.632 
 MDM 2,304 147 0.99 [0.72, 1.35] 1.87 0.244 
 FS 809,732 29,072 1.03 [0.82, 1.31] 1.60 0.586 
Abbreviations: CEM = Coarsened exact matching; CI = Confidence interval; FS = Fine stratification on the propensity score; MB = 
Mahalanobis balance; MDM = Mahalanobis distance matching; PSM = Propensity score matching; RR = Risk ratio. 









Table 6. Plasmode Analysis Results, Small Covariate Set, 20% Index Exposure Prevalence Interaction Scenarios – All 
Simulation Metrics 
Scenarioa,b Method Bias Variance Square Root of MSE AMB 
Default Crude -0.103 — — — 
 CEM 0.327 0.226 0.577 0.967 
 PSM 0.067 0.040 0.210 0.886 
 MDM 0.131 0.041 0.242 0.792 
 FS 0.070 0.027 0.178 0.946 
Exaggerated Crude -0.091 — — — 
 CEM 0.341 0.220 0.580 0.967 
 PSM 0.079 0.040 0.214 0.886 
 MDM 0.143 0.038 0.242 0.792 
 FS 0.080 0.023 0.172 0.946 
Abbreviations: AMB = Average proportion decrease in Mahalanobis balance; CEM = 
Coarsened exact matching; CI = Confidence interval; FS = Fine stratification on the 
propensity score; MDM = Mahalanobis distance matching; PSM = Propensity score 
matching.  
a The product term represented the interaction between age and Charlson comorbidity score. 
b The “default” scenario maintained the original product term and the “exaggerated” 









Table 7. Plasmode Analysis Results, Small Covariate Set, 20% Index Exposure Prevalence Interaction Scenarios – Absolute 
Differences between Index-exposed and Reference-exposed Groups with Respect to the Average of the Average Age, Within 


















Original CEMa PSM MDM FSa 
Average Age       
Within Score 0 2.09 0.05 0.38 0.47 0.28 
Within Score 1 2.03 0.11 0.25 0.42 0.15 
Within Score 2 1.66 0.11 0.06 0.45 0.14 
Within Score 3 1.93 0.01 0.16 0.94 0.07 
Within Score ≥ 4 1.43 0.02 0.25 0.99 0.31 
Average Score  
 
 
   
Within Age < 70 0.16 0.00 0.06 0.28 0.04 
Within Age 70-74 0.23 0.00 0.07 0.22 0.06 
Within Age 75-79 0.15 0.00 0.01 0.15 0.01 
Within Age 80-84 0.20 0.01 0.05 0.01 0.05 
Within Age 85-89 0.06 0.01 0.12 0.15 0.12 
Within Age 90-94 0.01 0.01 0.12 0.10 0.12 
Within Age ≥ 95 0.18 0.00 0.00 0.04 0.00 
Abbreviations: CEM = Coarsened exact matching; FS = Fine stratification on the 
propensity score; MDM = Mahalanobis distance matching; PSM = Propensity 
score matching; Score = Charlson Comorbidity Score. 
a The average age and average score values were weighted (at the unit level) for the 







Table 8. Results of the Example 1:1 Propensity Score Matching Without Replacement Analyses Using the Pharmaceutical 
Assistance Contract for the Elderly (1999-2002) Dataset 
1:1 PSM Method  Adjusted RRa,b SE (ln[RR]) 95% CI 95% CI 
Widthc 
Non-Bayesian     
Conventional, Simple SE 
Formula 
1.13 0.109 
[0.92, 1.40] 1.53 
Conventional, Log Binomial 1.13 0.109 [0.92, 1.40] 1.53 
Robust SE Log Binomial 1.13 0.109 [0.92, 1.40] 1.53 
Simple Bootstrap  1.13 0.111 [0.91, 1.41] 1.55 
Complex Bootstrap  1.13 0.106 [0.92, 1.40] 1.52 
Bayesian (BPSM)     
βprior ~ N(0, 0) 1.04 0.104 [0.84, 1.27] 1.51 
βprior ~ N(0, 1) 1.03 0.104 [0.84, 1.27] 1.51 
βprior ~ N(0, 1/10) 1.03 0.104 [0.84, 1.26] 1.50 
βprior ~ N(0, 1/100) 1.01 0.104 [0.82, 1.23] 1.50 
Abbreviations: BPSM = Bayesian 1:1 propensity score matching without replacement; CI = 
Confidence interval; 1:1 PSM = 1:1 propensity score matching without replacement; SE = Standard 
error; RR = Risk ratio. 
a The crude RR was 0.92. 
b The adjusted RR for the Conventional, Simple SE Formula was based on the corresponding simple 
contingency table-based formula. The same maximum likelihood-based adjusted RR estimate was 
used for the Conventional, Log Binomial, Simple Bootstrap and Complex Bootstrap scenarios. The 
adjusted RR for the Robust SE Log Binomial scenario was based on a generalized estimating 
equations model. The adjusted RR for the Bayesian scenarios was the exponent of the average value 
adjusted estimate across the matched datasets (generated from the MCMC-based logistic propensity 
score distribution).  
c The 95% CI width was calculated by dividing the upper 95% CI endpoint by the lower 95% CI 









Figure   1. Design Flowchart for the 36 Dataset Scenarios 
The Matching/Distance Metric and Matching Algorithm branches apply to each of the Index Exposure Prevalence branches. 








Figure   2. Forest Plots of Standardized Differences Among All Covariates for the 
PACE, Standard Covariate Set, Original Index Exposure Prevalence Dataset 
A) Fully-matched datasets. B) Matched datasets pruned to the sample size of the pruned 
dataset that first met the propensity score nearest neighbor matching 0.025 absolute 
propensity score distance caliper. The black, red, green and blue markers correspond to 
the covariates from the original/pre-matched dataset, from the propensity score nearest 
neighbor-matched dataset, from the propensity score digit-based greedy-matched dataset 










Figure   3. Forest Plots of Standardized Differences Among All Covariates for the MAX, 
Original Index Exposure Prevalence Dataset 
A) Fully-matched datasets. B) Matched datasets pruned to the sample size of the pruned 
dataset that first met the propensity score nearest neighbor matching 0.025 absolute 
propensity score distance caliper. The black, red, green and blue markers correspond to 
the covariates from the original/pre-matched dataset, from the propensity score nearest 
neighbor-matched dataset, from the propensity score digit-based greedy-matched dataset 










Figure   4. Mahalanobis Balance Metric Trends for the 9 PACE Datasets 
A) Small covariate set, original index exposure prevalence (IEP). B) Small covariate set, 
50% of IEP. C) Small covariate set, 20% of IEP. D) Standard covariate set, IEP. E) 
Standard covariate set, 50% of IEP. F) Standard covariate set, 20% of IEP. G) Large 
covariate set, IEP. H) Large covariate set, 50% of IEP. I) Large covariate set, 20% of 
IEP. The black dots indicate the Mahalanobis balance values of the pre-matched datasets. 
Red lines indicate propensity score nearest neighbor matching trends, green lines indicate 
propensity score digit-based greedy matching trends and blue lines indicate Mahalanobis 
distance matching trends. The dotted and dashed vertical lines (for propensity score 
nearest neighbor matching and propensity score digit-based greedy matching, 
respectively) mark the 6 points at which the propensity score matching trends first met 
the 0.05, 0.025 and 0.01 absolute propensity score distance caliper criteria (vertical line 
colors correspond to trend colors). The caliper criteria always were met in the order 0.05, 











Figure   5. Mahalanobis Balance Metric Trends for the 3 MAX Datasets 
A) Original index exposure prevalence (IEP). B) 400% of IEP. C) 700% of IEP. The black dots indicate the Mahalanobis 
balance values of the pre-matched datasets. Red lines indicate propensity score nearest neighbor matching trends, green lines 
indicate propensity score digit-based greedy matching trends and blue lines indicate Mahalanobis distance matching trends. 
The dotted and dashed vertical lines (for propensity score nearest neighbor matching and propensity score digit-based greedy 
matching, respectively) mark the 6 points at which the propensity score matching trends first met the 0.05, 0.025 and 0.01 
absolute propensity score distance caliper criteria (vertical line colors correspond to trend colors). The caliper criteria always 







Figure   6. C-statistic Metric Trends for the 9 PACE Datasets 
A) Small covariate set, original index exposure prevalence (IEP). B) Small covariate set, 
50% of IEP. C) Small covariate set, 20% of IEP. D) Standard covariate set, IEP. E) 
Standard covariate set, 50% of IEP. F) Standard covariate set, 20% of IEP. G) Large 
covariate set, IEP. H) Large covariate set, 50% of IEP. I) Large covariate set, 20% of 
IEP. The black dots indicate the Mahalanobis balance values of the pre-matched datasets. 
Red lines indicate propensity score nearest neighbor matching trends, green lines indicate 
propensity score digit-based greedy matching trends and blue lines indicate Mahalanobis 
distance matching trends. The dotted and dashed vertical lines (for propensity score 
nearest neighbor matching and propensity score digit-based greedy matching, 
respectively) mark the 6 points at which the propensity score matching trends first met 
the 0.05, 0.025 and 0.01 absolute propensity score distance caliper criteria (vertical line 
colors correspond to trend colors). The caliper criteria always were met in the order 0.05, 











Figure   7. C-statistic Metric Trends for the 3 MAX Datasets 
A) Original index exposure prevalence (IEP). B) 400% of IEP. C) 700% of IEP. The black dots indicate the Mahalanobis 
balance values of the pre-matched datasets. Red lines indicate propensity score nearest neighbor matching trends, green lines 
indicate propensity score digit-based greedy matching trends and blue lines indicate Mahalanobis distance matching trends. 
The dotted and dashed vertical lines (for propensity score nearest neighbor matching and propensity score digit-based greedy 
matching, respectively) mark the 6 points at which the propensity score matching trends first met the 0.05, 0.025 and 0.01 
absolute propensity score distance caliper criteria (vertical line colors correspond to trend colors). The caliper criteria always 







Figure   8. Zoomed-in Version of Figure 4 
A) Small covariate set, original index exposure prevalence (IEP). B) Small covariate set, 
50% of IEP. C) Small covariate set, 20% of IEP. D) Standard covariate set, IEP. E) 
Standard covariate set, 50% of IEP. F) Standard covariate set, 20% of IEP. G) Large 
covariate set, IEP. H) Large covariate set, 50% of IEP. I) Large covariate set, 20% of 
IEP. The ranges of the “No. Pruned” axes in these panels are much smaller than the 
ranges of the corresponding panels in Figure 1. The black dots indicate the Mahalanobis 
balance values of the pre-matched datasets. Red lines indicate propensity score nearest 
neighbor matching trends, green lines indicate propensity score digit-based greedy 
matching trends and blue lines indicate Mahalanobis distance matching trends. The 
dotted and dashed vertical lines (for propensity score nearest neighbor matching and 
propensity score digit-based greedy matching, respectively) mark the 6 points at which 
the propensity score matching trends first met the 0.05, 0.025 and 0.01 absolute 
propensity score distance caliper criteria (vertical line colors correspond to trend colors). 
The caliper criteria always were met in the order 0.05, 0.025, 0.01 during the pruning 











Figure   9. Zoomed-in Version of Figure 5 
A) Original index exposure prevalence (IEP). B) 400% of IEP. C) 700% of IEP. The ranges of the “No. Pruned” axes in these 
panels are much smaller than the ranges of the corresponding panels in Figure 1. The black dots indicate the Mahalanobis 
balance values of the pre-matched datasets. Red lines indicate propensity score nearest neighbor matching trends, green lines 
indicate propensity score digit-based greedy matching trends and blue lines indicate Mahalanobis distance matching trends. 
The dotted and dashed vertical lines (for propensity score nearest neighbor matching and propensity score digit-based greedy 
matching, respectively) mark the 6 points at which the propensity score matching trends first met the 0.05, 0.025 and 0.01 
absolute propensity score distance caliper criteria (vertical line colors correspond to trend colors). The caliper criteria always 







Figure 10. Relative Risk Estimate Trends for the 9 PACE Datasets  
A) Small covariate set, original index exposure prevalence (IEP). B) Small covariate set, 
50% of IEP. C) Small covariate set, 20% of IEP. D) Standard covariate set, IEP. E) 
Standard covariate set, 50% of IEP. F) Standard covariate set, 20% of IEP. G) Large 
covariate set, IEP. H) Large covariate set, 50% of IEP. I) Large covariate set, 20% of 
IEP. A dashed horizontal black line at the relative risk estimate value of 1.00 is included 
for reference. The black dots indicate the relative risk estimates of the pre-matched 
datasets. Red lines indicate propensity score nearest neighbor matching trends, green 
lines indicate propensity score digit-based greedy matching trends and blue lines indicate 
Mahalanobis distance matching trends. The dotted and dashed vertical lines (for 
propensity score nearest neighbor matching and propensity score digit-based greedy 
matching, respectively) mark the 6 points at which the propensity score matching trends 
first met the 0.05, 0.025 and 0.01 absolute propensity score distance caliper criteria 
(vertical line colors correspond to trend colors). The caliper criteria always were met in 











Figure 11. Relative Risk Estimate Trends for the 3 MAX Datasets 
A) Original index exposure prevalence (IEP). B) 400% of IEP. C) 700% of IEP. A dashed horizontal black line at the relative 
risk estimate value of 1.00 is included for reference. The black dots indicate the relative risk estimates of the pre-matched 
datasets. Red lines indicate propensity score nearest neighbor matching trends, green lines indicate propensity score digit-
based greedy matching trends and blue lines indicate Mahalanobis distance matching trends. The dotted and dashed vertical 
lines (for propensity score nearest neighbor matching and propensity score digit-based greedy matching, respectively) mark the 
6 points at which the propensity score matching trends first met the 0.05, 0.025 and 0.01 absolute propensity score distance 
caliper criteria (vertical line colors correspond to trend colors). The caliper criteria always were met in the order 0.05, 0.025, 









Figure 12. Plasmode Analysis Results, Non Interaction Scenarios – Average Proportional Decrease in Mahalanobis Balance 
A) Small covariate set scenarios. B) Standard covariate set scenarios. C) Large covariate set scenarios. Blue lines indicate 
coarsened exact matching trends, green lines indicate propensity score matching trends, purple line indicates Mahalanobis 
distance matching trend and red lines indicate fine stratification on the propensity score trends. IEP = Index exposure 









Figure 13. Plasmode Analysis Results, Non Interaction Scenarios – Square Root of Mean Squared Error, Including Coarsened 
Exact Matching Results 
A) Small covariate set scenarios. B) Standard covariate set scenarios. C) Large covariate set scenarios. Blue lines indicate 
coarsened exact matching trends, green lines indicate propensity score matching trends, purple line indicates Mahalanobis 
distance matching trend and red lines indicate fine stratification on the propensity score trends. IEP = Index exposure 









Figure 14. Plasmode Analysis Results, Non Interaction Scenarios – Square Root of Mean Squared Error, Excluding Coarsened 
Exact Matching Results 
A) Small covariate set scenarios. B) Standard covariate set scenarios. C) Large covariate set scenarios. Green lines indicate 
propensity score matching trends, purple line indicates Mahalanobis distance matching trend and red lines indicate fine 









Figure 15. Plasmode Analysis Results, Non Interaction Scenarios – Bias, Including Coarsened Exact Matching Results 
A) Small covariate set scenarios. B) Standard covariate set scenarios. C) Large covariate set scenarios. Black dots indicate the 
bias corresponding to the crude log risk ratio. Blue lines indicate coarsened exact matching trends, green lines indicate 
propensity score matching trends, purple line indicates Mahalanobis distance matching trend and red lines indicate fine 









Figure 16. Plasmode Analysis Results, Non Interaction Scenarios – Bias, Excluding Coarsened Exact Matching Results 
A) Small covariate set scenarios. B) Standard covariate set scenarios. C) Large covariate set scenarios. Black dots indicate the 
bias corresponding to the crude log risk ratio. Green lines indicate propensity score matching trends, purple line indicates 










Figure 17. Plasmode Analysis Results, Non Interaction Scenarios – Variance, Including Coarsened Exact Matching Results 
A) Small covariate set scenarios. B) Standard covariate set scenarios. C) Large covariate set scenarios. Blue lines indicate 
coarsened exact matching trends, green lines indicate propensity score matching trends, purple line indicates Mahalanobis 










Figure 18. Plasmode Analysis Results, Non Interaction Scenarios – Variance, Excluding Coarsened Exact Matching Results 
A) Small covariate set scenarios. B) Standard covariate set scenarios. C) Large covariate set scenarios. Green lines indicate 
propensity score matching trends, purple line indicates Mahalanobis distance matching trend and red lines indicate fine 









Figure 19. Depiction of the Usual Application of 1:1 Propensity Score Matching Without Replacement 
1:1 PSM = 1:1 propensity score matching without replacement; E = Exposed; U = Unexposed; Y = Outcome variable; Z = 








Figure 20. Depiction of the Usual Application of 1:1 Propensity Score Matching Without Replacement (Figure 1), Including 
Corresponding Pre-matched Samples 
1:1 PSM = 1:1 propensity score matching without replacement; E = Exposed; PS = Propensity score; U = Unexposed; X = 








Figure 21. Depiction of the Mechanics of Simple Bootstrap 1:1 Propensity Score Matching for Standard Error Estimation 
1:1 PSM = 1:1 propensity score matching without replacement; E = Exposed; PS = Propensity score; U = Unexposed; X = 









Figure 22. Depiction of the Mechanics of Complex Bootstrap 1:1 Propensity Score Matching for Standard Error Estimation 
1:1 PSM = 1:1 propensity score matching without replacement; E = Exposed; PS = Propensity score; U = Unexposed; X = 








Figure 23. Depiction of the Mechanics of Bayesian 1:1 Propensity Score Matching for Standard Error Estimation 
The “form” function represents the formula for the standard error used by Kaplan and Chen (2014). 1:1 PSM = 1:1 propensity 
score matching without replacement; E = Exposed; PS = Propensity score; U = Unexposed; X = Covariate vector; Y = 











DERIVATION OF THE WEIGHTING SCHEME FOR COARSENED EXACT 
MATCHING (CEM) AND FOR FINE STRATIFICATION ON THE PROPENSITY 
SCORE (FS) [Iacus et al., 2011; Iacus et al., 2011; Desai et al., 2017] 
 
For this exposition, let “treatment” stand for the index exposure of interest and 
“control” stand for the reference exposure.  
 
Assuming that the causal effect of interest is the average effect of treatment on the treated 
(ATT), the control group in the analytic dataset must be the counterfactual ideal for the 
treated group in the analytic dataset. From a statistical perspective, this means that the 
distribution of covariates in the entire control group must be the same as the distribution 
of covariates in the entire treated group (such equivalence approximates ignorability, 
which is required for recovery of the causal effect).  
 
Both CEM and FS attempt to balance the distributions of covariates between treated and 
control units within the context of strata, which are determined by the respective method 
(for CEM, the method is exact matching within coarsened boundaries that define the 
strata; for FS, the method is grouping of control units with estimated propensity score 
values that are similar to the estimated propensity score values of treated units, with 
individual groups [strata] defined by quantiles of the estimated propensity score 





To maximize the number of units that appear in the analytic dataset (i.e., to maximize 
statistical efficiency), both methods allow for multiple treated units and multiple control 
units to appear in a stratum, in a variable ratio across strata (i.e., the same numbers of 
treated and control units might not appear across strata). Because of the variable 
placement of units across strata, the distributions of covariates between treated units and 
control units within a given stratum, and, by extension, among all strata, are not 
necessarily comparable [Rassen et al., 2012]. Consequently, placement of units into strata 
does not necessarily guarantee that the covariate balance that actually is achieved by the 
method will be perceivable. However, covariate balance may be perceivable, prior to any 
analysis, via an appropriate weighting scheme.  
 
Let NiT be the total number of treated units in stratum i and NiC be the total number of 
control units in stratum i. Then NT (∑i NiT) is the total number of treated units in the 
analytic dataset (i.e., among all strata) and NC (∑i NiC) is the equivalent number of control 
units.  
 
One way to observe the covariate balance produced by CEM and FS in the resulting 
analytic dataset (i.e., to make the distributions of covariates between the treated and 
control units comparable) is to weight control units in each stratum so that the proportion 
of treated units across all strata who are in stratum i is the same as the proportion of 
control units across all strata who are in stratum i (the variable ratio placement for CEM 





requirement is:   
1. {NiT / NT = NiC / NC} ∀ i 
By rearranging the equation, it becomes clear that if this condition holds, the ratio of 
treated units to control units within each stratum is the same as the ratio of treated units to 
control units in the entire analytic dataset:  
2. {NiT / NiC = NT / NC} ∀ i 
Thus, the covariate distribution balance within each stratum will be correctly reflected in 
an analysis of the entire analytic dataset.  
 
By rearranging the equation in 1 again, it is clear that the following also is true:  
3. {(NiT / NT) / (NiC / NC) = 1} ∀ i 
In other words, if the condition represented by 1 holds, then the ratio of the proportion of 
treated units across all strata who are in stratum i to the proportion of control units across 
all strata who are in stratum i must be unity.  
 
If 3 does not hold in stratum i, then the following holds:  
4. (NiT / NT) / (NiC / NC) = ωi 
(where ωi ≠ 1). To ensure that 3 holds in stratum i, both sides of 4 must be divided by ωi:  
5. (NiT / NT) / ([ωi*NiC] / NC) = ωi /ωi = 1 
 
Therefore, ωi, is the weight that should be applied to each control unit in stratum i to 





units and for which 4 holds. Each of these 3 control units contributes a weight of 1 after 
performing CEM or FS (i.e., without any further weighting). Therefore, the following is 
true:  
6. NiC = (1 + 1 + 1) 
Thus, applying ωi to NiC as in 5 yields:  
7. ωi*NiC = ωi*(1 + 1 + 1) = (ωi*1 + ωi*1 + ωi*1) 
Hence, each control unit in stratum i receives ωi as its weight prior to any analysis in 
order to recover the condition represented by 3 and, thus, to reveal the extent of covariate 
balance achieved by CEM or FS. Using the weighted analytic dataset, the ATT may be 
estimated. 
 
Of note, the risk ratio that is weighted using this scheme is equivalent to the common 
measure of association, the standardized morbidity ratio [Rothman et al., 2008]. 
 
Example 
As an example, consider 2 strata from a hypothetical analytic dataset, resulting from an 
application of CEM. For this dataset, NT = 30 and NC = 50. The 2 strata are composed as 
follows.  
Stratum 1 Stratum 2 
# Treated Units # Control Units # Treated Units # Control Units 
2 3 4 1 
 





Stratum 1: ω1 = (2/30) / (3/50) = 1.1111 
Stratum 2: ω2 = (4/30) / (1/50) = 6.6667 
Thus, for stratum 1, each control unit should receive weight, 1.11 and for stratum 2, each 
control unit (the single control unit in this case) should receive weight, 6.67. For both 
strata, control units are up-weighted since, prior to weighting, the proportion of control 
units across all strata who are in the stratum is less than the proportion of treated units 
across all strata who are in the stratum (i.e., ωi > 1). To recover the condition represented 
by 3, the weights are applied as follows (rounding error allowed here).  
Stratum 1: (2/30) / ([1.11*3]/50) = 1 
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